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The maintenance of genome stability is fundamental for cell survival and loss of genome 
integrity in multicellular organisms is often associated with cancer. Cells have therefore 
developed a network of DNA repair systems and a signal transduction pathway, which leads 
to an arrest of cell cycle progression, in order to deal with DNA damage. DNA damage can 
arise as a result of normal cellular metabolism or exposure to chemical or physical agents in 
environment (Friedberg et al., 1995). 
Mutations in genes involved in defending of genome integrity lead to genome destabilization 
and elevated mutation rates. In humans, a number of inherited disorders are associated with 
genomic instability. These disorders include Ataxia telangiectasia (AT), an ataxia – like 
disorder (ATLD), Nijmegen breakage syndrome (NBS), Fanconi anemia (FA), Xeroderma 
pigmentosum (XP), Cockayne syndrome (CS), Trichothiodystrophy (TTD), Rothmund – 
Thomson syndrome (RT), Bloom syndrome (BS) and Werner syndrome (WS). 
 
1.1. Werner syndrome (WS) 
 Werner syndrome is a rare autosomal recessive disorder that is considered a model of 









Fig. 1. Premature aging symptoms in Werner syndrome: Japanese American as a teenager 





WS patients usually develop normally until they reach second decade of life. Growth 
retardation begins to appear typically during puberty and the full symptoms in individuals 20 
– 30 years of age. Major age – related symptoms include graying and loss of hair, skin 
atrophy, atherosclerosis, osteoporosis, bilateral cataracts and diabetes mellitus (type II). 
Additionally, WS individuals also manifest a high incidence of cancer and other non – age – 
related symptoms, such as short stature, reduced fertility, hypogonadism, ulceration around 
the ankles and soft tissue calcification. Patients usually die of either cardiovascular disease or 
cancer at a medium age of ~ 47 years. Otto Werner originally defined Werner syndrome in 
1904 on the basis of bilateral cataracts, scleroderma and premature graying and loss of hair. 
The genomic instability is on the cellular level manifested as chromosome breaks, reciprocal 
chromosomal translocations (Salk et al., 1981), extensive genomic deletions (Fukuchi et al., 
1989) and attenuated apoptosis. Furthermore, WS cells are also characterized by defects in 
DNA replication, DNA recombination, DNA repair, transcription and telomere maintenance. 
Werner syndrome is very rare. The estimated incidence is between 1 and 22 cases per million. 
This desease is more common in Japan, where more than 800 cases were found out of about 
1200 reported in the world. 
 
1.2. Product of Werner syndrome gene 
Aging researches have long wondered what kind of genetic defect could cause the premature 
aging phenomenon of Werner syndrome. In 1992 Makoto Goto from Tokyo Metropolitan 
Otsuka Hospital and his colleagues performed a genetic linkage study in order to find out the 
primary defect of this disorder and had reported that WS mutation is located on the short arm 
of chromosome 8 (Goto et al., 1992). At that time Gerard D. Schellenberg’s group and other 
teams began to look for the Werner syndrome gene. He and his coworkers identified this gene 
by positional cloning in 1996 as a first gene associated with aging. The Werner syndrome 




exon (Yu et al., 1997), and encodes a from cDNA predicted  protein of 1432 amino acids with 
similarity to RecQ DNA helicases (Yu et al., 1996). 
 
1.2.1. RecQ DNA helicases 
The RecQ family of helicases is named after the RecQ protein from Escherichia coli. The 
gene recQ was originally identified by genetic analysis of a thymineless death–resistant 
mutant (Nakayama et al., 1984). The RecQ proteins are evolutionary conserved across 
species. Homologues have been found also in Saccharomyces cerevisiae, 
Schizosaccharomyces pombe, Neurospora crassa, Caenorhabditis elegans, Xenopus laevis, 
Drosophila melanogaster, Mus musculus and Homo sapiens. In general, E. coli and lower 
eukaryotes such as S. cerevisiae and S. pombe contain single RecQ helicase, whereas most 
higher organisms express more RecQ family members – five have been found so far in 
humans. Mutations of three human RecQ genes give rise to severe genetic disorders: Bloom 
syndrome (Ellis et al., 1995), Rothmund – Thomson syndrome (Kitao et al., 1999) and 
Werner syndrome, already described above. 
RecQ helicases can be divided into two groups by size. One group, including proteins such as 
human Werner syndrome protein (hWRN-p), Bloom syndrome protein (hBLM-p), Rothmund 
– Thomson syndrome protein (hRECQ4-p), Sgs1 from Saccharomyces cerevisiae, Rqh1 from 
Schizosaccharomyces pombe, FFA-1 and BLM from Xenopus laevis, BLM from 
Caenorhabditis elegans and Drosophila melanogaster and finally the biggest RecQ family 
member QDE-3 from Neurosporra crassa, are 1200 – 1900 amino acids in length. The second 
group includes the RecQ prototype from E. coli and other RecQ family members of 400 – 







Fig. 2. Schematic structure of RecQ proteins of various organisms. Abbreviated names of the 
organisms are Ec: Escherichia coli, Sc: Saccharomyces cerevisiae, Sp: Schizosaccharomyces 
pombe, Nc: Neurospora crassa, Ce: Caenorhabditis elegans, Dm: Drosophila melanogaster, 
Xl: Xenopus laevis, Hs: Homo sapiens, Mm: Mus musculus). The sizes of the proteins (aa: 
amino acid) are indicated on the right. The proteins were aligned according to the helicase 





All RecQ proteins share a highly conserved helicase domain (Figure 2) that comprises 
approximately 450 amino acids and includes seven sequence motifs (I, Ia, II, III, IV, V and 
VI) found in a wide variety of DNA and RNA helicases. These motifs are necessary for ATP 
binding and hydrolysis to obtain energy for nucleic acids unwinding. The eighth motif, motif 
0, was identified and characterized very recently by proteolytic mapping of terminal domains 
of E. coli RecQ and it was shown that motif 0 is indispensable for the DNA dependent 
ATPase and helicase function (Bernstein and Keck, 2003). Nucleotide binding sequence (so – 
called Walker A and B – boxes) is present in motif I and the for RecQ family characteristic 
DExH – box in motif II. RecQ helicases can be further distinguished from other helicases by 
the RQC (RecQ family C terminal) domain located just C–terminal to helicase domain. The 
RQC domain can be found in most RecQ family members and is supposed to have a role in 
mediating protein-protein interaction. At the C–terminal region of many RecQ helicases is 
also present the HRDC (helicase and RNaseD C–terminal) domain (Liu et at., 1999). This 
auxiliary domain is probably involved in stable binding to DNA or RNA. The lack of this 
domain doesn’t impede catalytic function (Bernstein and Keck, 2003). In certain RecQ 
enzymes, a nuclear localization signal (NLS) is located near the C – terminus of the protein. 
Outside of these domains, there is only little sequence similarity amongst the RecQ family 
members. These non-conserved regions may be required for other activities or interactions 
with another proteins, which could determine the mode of action of each helicase. Stretches of 
acidic amino acids similar to those found in transcriptional activators can be also identified 
within some proteins. 
There are also exceptions to this general rule of RecQ helicases organisation. Human Werner 
syndrome protein (hWRN-p), its orthologue Xenopus laevis FFA-1 and mouse Werner 
syndrome protein (mWRN-p) contain additionally a conserved nuclease domain of 
approximately 160 amino acids with similarity to bacterial RNaseD, human polymyositis – 




WS patients)  and the 3’ → 5’ proofreading exonuclease domain of E. coli DNA polymerase I 
in the N – terminal region. This domain spans amino acids 78 – 219 and is composed from 3 
highly conserved motifs (I, II and III) (Moser et al., 1997; Mushegian et al., 1997). 
Additionally, there has been a number of conserved residues outside these motifs identified by 
sequence analysis to be present in enzymes having proofreading exonucleolytic activities 
(Shevelev and Hübscher, 2002). Schematic structure of the functional domains of the human 
Werner syndrome protein is shown in Figure 3. 
 
 
Fig. 3. Schematic structure of the functional domains of the human Werner syndrome protein. 
Arabic numbers represent amino acids of the WRN protein. The functional domains are 
indicated. The exonuclease domain is composed from 3 highly conserved motifs (I – III). A 
nonhelicase domain consisting of a direct repeat of 27 amino acids located upstream to the 
helicase motifs is involved in transcriptional activation (Balajee, 1999). The helicase domain 
carrying also ATPase function consists of 8 motifs (0 – VI). The nuclear localization signal 
corresponds to amino acids 1370 – 1375. 
 
1.2.2. Mutations in Werner syndrome gene 
The studies of DNA samples obtained from WS patients showed that all mutations occur over 
the WRN gene and lead to truncation of the protein (Figure 4). The known mutations are stop 
codons, insertions or deletions and splice – site mutations, that result in a frame shift. 
Interestingly, no missense mutations has been detected in Werner syndrome cases. The loss of 
nuclear localization signal caused by the truncation of the WRN protein is predicted to result 




mutations does not influence the WS phenotype and suggests that Werner syndrome is a result 




Fig. 4.  Selected mutations found in Werner syndrome patients. The rectangular boxes 
indicate the functional domains of the WRN protein (see Figure 3). The nonsense mutations 
are shown as an X, insertions/deletions, which result in frame shift, as an arrow and splicing 
mutations as a triangle. The most frequent mutation (R367Stop) seen in Werner syndrome 
patients of Caucasian origin is indicated by the X in square brackets and the second most 
common mutation (deletion of exon 26) in Japanese Werner syndrome patients is indicated by 
the red triangle. 
 
1.3. Catalytic activities of human Werner syndrome protein (hWRN-p) 
The human Werner syndrome protein is a 1432 amino acid protein with a calculated 
molecular mass of 160 kDa. Characterization of the motifs of the WRN gene product 
indicated that hWRN-p should contain 3 catalytic activities: exonuclease, helicase and 
ATPase. Many researches tried to express the gene in variety of systems, such as in E. coli, 
yeast or in reticulocyte – based protein - synthesizing system in vitro and failed to obtain the 
active enzyme. The first evidence that hWRN-p encodes an active helicase came in 1997 from 
two independent laboratories. Noriyuki Suzuki from Tokyo Metropolitan Otsuka Hospital and 
Matthew D. Gray from University of Washington in Seattle and their coworkers demonstrated 
that the Werner syndrome protein expressed in insect cells using a recombinant baculovirus 




al., 1997). One year later, the exonucleolytic activity of hWRN-p was confirmed (Huang et 
al., Shen et al. and Kamath-Loeb et al., 1998). 
 
1.3.1. WRN helicase and ATPase activities 
Helicases are found in all living organisms and are required for many processes of nucleic 
acid metabolism, such as DNA replication, DNA repair, DNA recombination and 
transcription. Helicases are enzymes that convert double–stranded nucleic acids into single–
stranded nucleic acids using the energy derived from the hydrolysis of nucleoside 
triphosphates (NTP) in the presence of Mg2+ ions (Fig. 5). Helicases can be divided into 
different groups according to their structure and biochemical properties. One classification is 
according to their directionality of unwinding. They are either 5’  3’ or 3’  5’ helicases 
with respect to the strand they bind to and move along (Fig. 6 A and B). This classification is 
actually only possible for those helicases that bind a single–stranded nucleic acid terminus 
and then translocate along that single–stranded tail to start the unwinding at the single–
stranded/double–stranded junction. Helicases can be further classified according to the nucleic 
acid substrate they unwind – DNA or RNA helicases. Some helicases can unwind both, DNA 
and RNA. Another method of classification is based on their conserved sequences. They can 
be divided into families and superfamilies. Finally, helicases can be grouped according to 
their quarternary and oligomeric structures. 
Based on the sequence alignment, the Werner syndrom protein belongs to the RecQ family of 
DNA helicases. The unwinding of partial duplex DNA proceeds in the 3’  5’ direction 
(Gray et al., 1997; Shen et al., 1998). The WRN helicase activity is completely dependent on 
the hydrolysis of nucleoside triphosphates (NTPs or dNTPs). A study done by Shen and his 
coworkers in 1998 revealed that ATP, dATP, CTP and dCTP can promote strand– 
displacement. WRN helicase utilizes ATP and dATP preferentially. On the contrary, neither 



















Fig. 5. The nucleic acid unwinding by the helicase. The helicase is bound to one of the single 
strands. The hydrolysis of ATP allows her to move along the bound strand and disrupt the 
hydrogen bonds holding the two nucleic acid strands together.  
 
 
The hydrolysis of ATP is completely dependent on the presence of DNA and results in γ-
phosphate (Suzuki et al., 1997). The structure of DNA influences the WRN helicase activity. 
Short 24 nt DNA fragments are more easily unwound than the 40 nt long fragments, but the 
efficiency of unwinding of 40 nt fragments with additional 10 nt single-stranded ends (forked 
DNA, see Figure 7) is similar to that determined for 24 nt short fragments. Additionally, the 






Fig. 6. The schematic diagram depicting the directionality of unwinding. The directionality is 
determined by the strand on which the helicase binds and moves along. 
 
To get a hint of possible in vivo roles of Werner syndrome protein the studies on DNA 
substrate specificity were expanded (summarized in Figure 7 and 8). The first report that 
hWRN-p is a DNA processing protein for abberant DNA structures was published in 1999. 
DNA tetraplex, known also as G-quadruplex, is a four–stranded DNA structure containing 
guanine tetrads stabilized by Hoogsteen hydrogen bonds. G-quadruplex (G4) forming 
sequences can be found at different G-rich regions such as the fragile X chromosome, 
telomeric repeats, the immunoglobulin heavy chain switch region and ribosomal DNA 
(rDNA) gene clusters (Sen and Gilbert, 1988). The WRN helicase can unwind a bimolecular 
tetraplex structure of the expanded fragile X syndrome repeat sequence d(CGG)n with either 
3’ or 5’ single-stranded tail more efficiently than double-stranded DNA. On the contrary, 
hWRN-p fails to unwind blunt-ended bimolecular d(CGG)n tetraplex, blunt-ended or 5’-tailed 
bimolecular tetraplex structures of the vertebrate telomeric sequence d(TTAGGG)n and blunt-
ended or 5’-tailed tetramolecular quadruplex structures of an IgG switch region sequence (Fry 
and Loeb, 1999). Two years later three other synthetic G4 substrates were tested. One 
substrate containing a single-stranded 3’-DNA tail represented a consensus repeat from the 
murine immunoglobulin Sγ2b switch region, the other two substrates contained Oxytricha 
telomeric repeat sequence – one of them had again 3’-DNA tail. In these assays hWRN-p was 




formed from Oxytricha telomeric repeat sequence was not unwound. The authors suggested 
that the lack of WRN helicase activity on tetraplex structures of either IgG switch region 
sequence or vertebrate telomeric repeats in the previous study is most probably due to the 
absence of a 3’-DNA tail (Mohaghegh et al., 2001). The ability of some RecQ-helicases, 
including hWRN-p, to disrupt G-tetraplex DNA structures further inspired researchers to 
investigate, whether these helicases can be inhibited by ligands binding the telomeric 
quadruplex DNA, which are potent inhibitors of the telomerase enzyme complex. They 
showed that di- and trisubstituted acridine ligands are also inhibitors of the unwinding activity 
of Werner syndrome protein using G-quadruplex and three non-G4 substrates – the synthetic 
X-junction, the bubble and the forked partial duplex (Li et al., 2001). Moreover, G4 DNA and 
G-G pairing are expected to exist in the large telomere repeat DNA complex (TRDC) 
generated by PCR as a model of an extra-chromosomal telomere repeat (ECTR) DNA found 
in telomerase-negative immortalized cell lines, which consists of non-covalently linked 
single-stranded telomere repeat units. The hWRN-p is able to dissociate TRDC to single-
stranded DNAs in the presence of hRPA (Ohsugi et al., 2000).    
Furthermore, the hWRN-p can promote branch migration of Holliday junction recombination 
intermediate. As mentioned previously, the WRN helicase is unable to unwind DNA fragment 
longer than 40 bp from duplex DNA. In this report, the unwinding of the recombination 
intermediates by migration of the junction through more than 2700 bp has been demonstrated. 
The branch migration by hWRN-p is initiated at the junction. This was shown using RuvA, 
which has a high affinity for Holliday junctions and can act as a competitor. (Constantinou et 
al., 2000). Not surprisingly, the WRN helicase unwinds also the synthetic Holliday junction 
(Mohaghegh et al., 2001).  
Another DNA structure that can be unwound by WRN helicase is a triple helix. The third 
strand is usually polypurine or polypyrimidine and lies in the major groove of double-




the family of RecQ-helicases (Brosh et al., 2001a). The Werner syndrome protein is also 
capable to unwind DNA triplex with a 3’-single-stranded tail without a requirement for a fork 
or a long duplex region, but fails to unwind DNA triplexes with a 5’- or no single-stranded 
tail. On the other hand, the fork is required for the dissociation of duplex DNA substrates. 
DNA substrates containing a fork or a single-stranded tail are also unwound by WRN helicase 
(Brosh et al, 2002a). The length for optimal unwinding of forked DNA duplexes is about 10 
nucleotides for both tails and the usual 3’  5’ helicase substrate (partial duplex with a 3’-
single-stranded overhang) is unwound relatively inefficiently. To further characterize the 
requirement for 3’-single stranded overhang, a biotin-strepavidin complex was incorporated 
into the usual 3’  5’ helicase DNA substrate, either at the terminal 3’-nucleotide of the 
single-stranded overhang or 6 nucleotides away from the junction in the same DNA strand. 
The WRN helicase was unable to unwind the DNA containing the block close to the junction, 
but when the block was incorporated into the forked DNA, the WRN helicase unwinding 
activity was restored. A similar observation was made for the 5’-single-stranded flap DNA, 
one of the important intermediates of DNA replication and/or DNA repair. This suggests that 
hWRN-p doesn’t need a 3’-single-stranded overhang to bind to the forked DNA substrate. 
Most probably, hWRN-p preferentially recognizes the fork-flap structure to initiate the 
unwinding. The WRN helicase can also unwind synthetic replication forks.  
As already described, single-stranded regions are sometimes important for the WRN helicase 
unwinding of various DNA substrates. What happens, when such single-stranded DNA is 
centrally located in the blunt-ended DNA substrate (bubble structure)? The WRN helicase can 
efficiently unwind a 12 nt bubble structure. An 8 nt bubble-containing DNA substrate is 
unwound to only a limited extent and the substrate with a 4 nt bubble doesn’t promote any 
unwinding (Mohaghegh et al., 2001).    
A displacement loop (D-loop) DNA is similar to a bubble structure (Figure 8). Such D-loop is 




maintenance processes. The structure arises by the invasion a single-stranded DNA with a 3’-
end into the homologous duplex. It has been demonstrated that the helicase activity of 
hWRN-p efficiently displaces the invading strand from the substrate, converting the D-loop 
into a bubble (Orren et al., 2002).    
The WRN helicase activity is most efficiently inhibited by two minor groove binders - 
netropsin and distamycin A (Brosh et al., 2000). 
 
1.3.2. WRN exonuclease activity 
Exonucleases can degrade nucleic acids either from the 3’-terminus (3’  5’ direction) or 
from the 5’-terminus (5’  3’ direction). Three reports decribed that WRN exonuclease 
hydrolyzes the DNA in 3’  5’ direction (Huang et al., Shen et al. and Kamath-Loeb et al., 
1998). The  substrate  specificity  studies  revealed  that  its  preferred  substrate  is  a recessed  
strand of a partial DNA duplex. On the contrary, WRN exonuclease cannot degrade 3’-
protruding strand, blunt-ended DNA duplex and single-stranded DNA. The DNA degradation 
results in free 5’-deoxy-monophosphates (5’-dNMP) residues. To investigate, how the 
modified 3’-terminal nucleotide influences the ability of WRN exonuclease to initiate and 
further continue the DNA degradation, substrates with 3’-PO4 recessed terminus, with a 
completely matched and with one or two mismatched nucleotides at the 3’-end have been 
tested. The DNA substrates terminating with either 3’-OH or 3’-PO4 group are degraded to a 
similar extent. A single 3’-mismatched nucleotide is removed more efficiently from the DNA 
than a nucleotide, which is matched. Two 3’-mismatched nucleotides are degraded only 
barely. The exonuclease is stimulated by ATP, dATP, ΑΤPγS, CTP and dCTP at specific 
protein to DNA molar ratios (Kamath-Loeb et al., 1998). Interestingly, UTP and dTTP could 
also enhance the exonuclease activity under the conditions used, but as described already 
above, these nucleoside triphosphates don’t promote a strand-displacement catalyzed by the 










Fig. 8. The examples of DNA substrates that are either unwound or not unwound by helicase 
of hWRN-p. 
 
The secondary DNA structures are not only the substrates for the WRN helicase (summarized 
in Figure 9). It has been reported that hWRN-p extensively degrades substrates containing a 
bubble DNA, a stem-loop, a single-stranded loop and a single-stranded loop with a single-
stranded nick. These secondary structures together with 3- and 4-way junctions stimulate 
WRN exonuclease activity on blunt ends (Shen and Loeb, 2000). The 3’-end of the inserted 
strand of D-loop DNA structure is efficiently digested by hWRN-p (Orren et al., 2002).  
The 3’  5’ exonucleolytic activity of hWRN-p is inhibited by DNA modifications such as 8-




including uracil, hypoxanthine and ethenoadenine don’t inhibit the WRN exonuclease 
(Machwe et al., 2000).  
 
1.3.3. Influence WRN 3’  5’ helicase and 3’  5’ exonuclease each other? 
The two activities of the Werner syndrome protein can be separated from each other. Two 
point mutations in the exonuclease domain (D82A and E84A) abolish the 3’  5’ 
exonucleolytic activity, but do not affect the activity of helicase (Huang et al., 1998). 
Similarly, the amino acid substitution in the helicase domain (K577M) disables the ATPase 
and 3’  5’ helicase activities, but retains the activity of the exonuclease (Huang et al. and 
Shen et al., 1998). 
The helicase and exonuclease activities are separable also physically. The N-terminal 
fragments of hWRN-p, such as 1-333 aa (Huang et al., 1998 and 2000) , 1-368 aa (Shen et al., 
1998; Machwe et al., 2000 and 2002) and 70-240 aa (Xue et al., 2002) exhibit the 
exonucleolytic function. On the contrary, the truncated version of hWRN-p lacking the 
exonuclease domain (266-1167 aa) displays helicase activity, but no exonuclease activity 
(Shen et al., 1998). The substrate specificities of the WRN exonuclease and the truncated 
protein containing only first 333 aa are similar (Kamath-Loeb et al., 1998; Huang et al., 
2000). However, the exonucleolytic activity of the N-terminal fragment 1-368 aa on 
substrates containing an apurinic site or ethenoadenine slightly differs from that of hWRN-p 
(Machwe et al., 2000). More importantly, this 368 aa – exonuclease is unable to degrade 
bubble DNA substrates, which are efficiently hydrolyzed by hWRN-p (Machwe et al., 2002).  
Although the activities of the  helicase and  the  exonuclease  are separable, they  influence 
each other. The helicase dissociates the DNA at the forked end of the substrate, whereas the 
exonuclease digests at the blunt end. The unwinding of forked duplexes is more rapid than the 






Fig. 9. The examples of DNA substrates degraded or not degraded by 3’  5’ WRN 




digestion by unwinding the DNA substrate. Both activities together can then remove the DNA 
strands that are not efficiently unwound by the helicase activity alone (Opresko et al., 2001). 
 
1.4. The Werner syndrome homologues from Mus musculus and Xenopus 
laevis 
It has been shown, that the substrate specificity of the mouse 3’  5’ WRN exonuclease is 
similar to that of human WRN exonuclease. The exonucleolytic activity of the N-terminal 
regions of hWRN-p (1-333 aa) and mWRN-p (1-328 aa) were compared. The activity of 
mouse WRN exonuclease was slightly reduced compared to the human WRN exonuclease 
(Huang et al., 2000).  
Replication foci are discrete sites in the interphase nucleus composed of clusters of small 
replicons. The focus forming activity 1 (FFA-1) protein from Xenopus laevis is a 3’  5’ 
DNA helicase involved in the assembly of replication foci (Yan et al., 1998). The FFA-1 
colocalizes and interacts with the replication protein A (RPA) and the FFA-1 helicase activity 
is by RPA strongly stimulated (Chen et al., 2001). 
   
1.5. Proteins that interact physically and/or functionally with hWRN-p 
The broad spectrum of DNA structures that are processed by either WRN helicase or WRN 
exonuclease activity suggests that hWRN-p may function in diverse DNA metabolism 
pathways.  The identification of hWRN-p-interacting proteins can delineate the pathways in 
which this protein participates.  
                                                                                                           
1.5.1. Proteins involved in transcription 
Compared to the wild-type lymphoblastoid cells, the level of transcription in Werner 




associated with the RNA-polymerase II (RNA pol II), but not with the RNA polymerase I 
(RNA pol I).  The addition of the hWRN-p to the nuclear extract from the normal 
lymphoblastoid cells resulted in the stimulation of the RNA pol II-specific transcription in 
vitro. Neither the hWRN-p lacking the transcriptional activation region (see Figure 3) nor the 
hWRN-p mutant K577M could significantly stimulate the transcription (Balajee et al., 1999). 
Interestingly, WS fibroblasts are characterized by a reduction of rRNA transcription mediated 
by RNA polymerase I compared with the wild-type cells. The hWRN-p is associated with an 
RNA pol I subunit RPA40. Furthermore, the expression of hWRN-p restores the rRNA 
transcription in WS fibroblasts to that of normal cells (Shiratori et al., 2002). 
 
1.5.2. Proteins involved in DNA replication 
1.5.2.1. Human replication protein A  
The human replication protein A (hRPA) is a single-strand binding protein composed of three 
subunits 70, 32 and 14 kDa. hRPA is required for DNA replication, recombination and repair. 
The WRN helicase is strongly stimulated by hRPA (Shen et al., 1998). The hWRN-p alone is 
unable to unwind a partial duplex longer than 40 bp, but in the presence of hRPA the 
unwinding of long partial duplex DNA substrates up to 849 bp has been detected. This 
functional interaction between hWRN-p and hRPA appears to be specific. The stimulation of 
WRN helicase activity by hRPA is neither due to enhanced ssDNA-dependent ATPase 
activity of hWRN-p nor due to hRPA-binding to the single DNA strands resulting from DNA 
duplex unwinding. Taken together with the experiments with a DNA competitor, the data 
suggest that hRPA does not increase the processivity of hWRN-p. Furthermore, a direct 
interaction between hWRN-p and hRPA has been demonstrated. (Brosh et al., 1999). Human 
RPA stimulates also the unwinding of a telomere repeat DNA complex (TRDC), as described 
already above (Ohsugi et al., 2000). In addition, the hWRN-p is recruited from the nucleoli to 




by depletion of the cellular dNTP pool after hydroxyurea treatment (Constantinou et al., 
2000).  
 
1.5.2.2. DNA polymerase δ 
The DNA polymerase δ is an eukaryotic polymerase participating in DNA replication and 
DNA repair. Cells from WS individuals display DNA replication defects. The hWRN-p 
selectively stimulates the polymerization activity of DNA polymerase δ in the absence of 
proliferating cell nuclear antigen (PCNA) (Kamath-Loeb et al., 2000). The physical 
interaction of hWRN-p with the p50 subunit of DNA polymerase δ was confirmed by yeast 
two-hybrid analysis. The interaction is mediated by the C-terminus of hWRN-p. The hWRN-p 
coimmunoprecipitates with the p50 subunit. The catalytic subunit p125 of DNA polymerase δ 
is also present in the precipitate. Both subunits co-localize with hWRN-p in the nucleolus, 
indicating that hWRN-p recruits DNA polymerase δ to the nucleolus to facilitate the DNA 
replication progression probably by resolving unusual DNA secondary structures (Szekely et 
al., 2000). Hairpin and bimolecular d(CGG)n tetraplex DNA structures severaly impede DNA 
synthesis by three eukaryotic DNA polymerases - α, δ and ε. The addition of hWRN-p into 
the primer-extension reaction allows DNA polymerase δ to traverse the template secondary 
structures and generate full-length DNA products, but doesn’t facilitate the DNA synthesis 
performed by polymerase α and δ (Kamath-Loeb et al., 2001). 
 
1.5.2.3. PCNA and topoisomerase I 
The eukaryotic proliferating cell nuclear antigen (PCNA) is a trimeric protein that acts as a 
sliding clamp to increase the processivity of DNA polymerization. The mouse WRN-p 
(mWRN-p) co-purifies with the 17S multiprotein DNA replication complex and co-




experiments revealed that the N-terminal part of mWRN-p is responsible for the interaction 
(Lebel et al., 1999). Furthermore, the hWRN-p also co-immunoprecipitates with PCNA 
(Huang et al., 2000) and binds PCNA at physiological protein concentrations in normal 
fibrobloblasts. Both PCNA and hWRN-p co-localize to sites of active DNA replication 
(Rodriguez-Lopez et al., 2003). A 70-240 aa N-terminal fragment of hWRN-p interacts with 
PCNA (Xue et al., 2002).   
The eukaryotic topoisomerase I is a monomeric enzyme that has been found to be also a 
component of the 17S replication complex. The interaction between the hWRN-p and 
topoisomerase I  was confirmed by immunoprecipitation experiments (Lebel et al., 1999). 
 
1.5.2.4. Flap endonuclease 1 
The flap endonuclease 1 (FEN-1) is a structure specific endo- and 5’→3’ exonuclease 
involved in DNA replication, recombination and repair. It has been shown that the hWRN-p 
binds with its C-terminal part to FEN-1 and stimulates FEN-1 cleavage activity. The 
stimulation is independent of hWRN-p activities - the WRN mutant K577M lacking the 
ATPase and helicase activities and the exonuclease mutant E84A are able to stimulate FEN-1 
incision. The hWRN-p can stimulate not only the FEN-1 cleavage of 1 nt 5’-flap, but also the 
cleavage of longer 5’-flap of 5 nt or an incision of the nicked DNA substrate (Brosh et al., 
2001c). The FEN-1 cleavage of DNA replication intermediate, flap substrate with a terminal 
ribonucleotide, longer 5’-flaps (such as 26 or 80 nt), that may arise during the lagging strand 
synthesis or pseudo-Y forked structures, is efficiently stimulated by hWRN-p. The optimal 
stimulation of FEN-1 cleavage requires that WRN helicase doesn’t unwind the 5’-flap 







1.5.2.5. Werner helicase interacting protein  
The mouse Werner syndrome protein interacts with a so called Werner helicase interacting 
protein (WHIP), which is evolutionary conserved (Kawabe et al., 2001). In Saccharomyces 
cerevisiae was the WHIP also named as a Maintenance of Genome Stability 1 (MGS1). The 
protein is a DNA-dependent ATPase with a similarity to the eukaryotic replication factor C3 
and to E. coli Holliday junction branch migration protein RuvB. A mutation in 
Saccharomyces cerevisiae Sgs1 gene, which encodes for only member of RecQ DNA helicase 
family in this organism, suppresses the slow growth phenotype of a top3 (type-IA 
topoisomerase) mutant. The effect of Mgs1 mutation on the slow growth defect of top3 
mutant is opposite. Opposite to the Sgs1 DNA unwinding function, the Mgs1 reveals a single-
strand annealing activity. It suggests, that all three proteins together, Mgs1, RecQ and DNA 
topoisomerase, may participate in the maintenance of genome stability during DNA 
replication (Hishida et al., 2001).  
 
1.5.3. Proteins involved in a maintenance of genome stability 
1.5.3.1. p53 
The tumor suppressor protein p53 functions as a guardian of the genome integrity via its 
involvement in various DNA metabolic pathways. The fibroblasts from Werner syndrome 
patients have an attenuated p53-mediated apoptotic response. The immunoprecipitation 
analysis and in vitro binding assays revealed that hWRN-p interacts with p53 and binds to its 
C-terminus. Moreover, the expression of hWRN-p in WS cells restores the p53-mediated 
apoptosis to normal levels. (Spillare et al., 1999). For the specific interaction with p53 is 
responsible the C-terminus of hWRN-p. The p53 activates the sequence-specific transcription 
of target genes. The hWRN-p enhances the transcriptional activity of p53 driven from 
different p53-specific promoters (Blander et al., 1999). On the other hand, p53 suppresses the 




exonuclease activity by a direct interaction with the C-terminus of hWRN-p. The binding of 
p53 to the DNA substrate may contribute to the WRN exonuclease inhibition. The helicase 
and ATPase function of hWRN-p are not affected by p53 on the short 28 bp M13 partial DNA 
duplex substrate (Brosh et al., 2001b), but the helicase is inhibited by p53 on the synthetic X-
junction. The phosphorylation of p53 at Ser378 reduces the WRN helicase inhibition (Yang et 
al., 2002).  Similar to hRPA, p53 co-localizes with hWRN-p in the nucleoplasm after the 
treatment of cells with hydroxyurea (Brosh et al., 2001b). 
 
1.5.3.2. TRF2 
The TTAGGG repeat binding factor 2 (TRF2) has been shown to induce the invasion of 3’-
single-stranded tail of TTAGGG repeat into duplex telomeric DNA, forming a structure 
called telomeric loop (t-loop) (Greider, 1999). This structure is believed to protect telomeric 
ends. The TRF2 binds with a high affinity to hWRN-p primarily via RecQ C-terminal domain 
and stimulates WRN helicase activity, but doesn’t influence the activity of WRN exonuclease. 
Moreover, the helicase activity of hWRN-p together with RPA is not inhibited by TRF2 
bound on the DNA substrate (Opresko et al., 2002).   
 
1.5.3.3. DNA-PK and Ku 
The DNA-dependent protein kinase (DNA-PK) is composed of a DNA-dependent catalytic 
subunit (DNA-PKCS) and the Ku70/80 heterodimer. This complex is required for DNA 
double-strand break repair by non-homologous end joining (NHEJ). The Ku70/80 
heterodimer binds to broken DNA ends and then associates with DNA-PKCS. There are some 
conflicting data concerning the role of hWRN-p in association with DNA/DNA-PK complex 
and the role of DNA-PK in regulation of hWRN-p activity. It has been shown that the hWRN-
p stabilizes the DNA/DNA-PK complex and is phosphorylated in vivo by DNA-PK (Yannone 




from the DNA/Ku70/80 complex. For this displacement both Ku binding sites on hWRN-p 
are required (Li and Comai, 2002).  The WRN exonuclease activity is not influenced by 
DNA-PKCS (Karmakar et al., 2002a; Li and Comai, 2002). On the other hand, the inhibition 
of both activities of hWRN-p by DNA-PKCS has been reported. The presence of Ku70/80 
reduced the inhibition of hWRN-p (Yannone et al., 2001). The opposite effect of Ku70/80 on 
hWRN-p activity has been observed - most probably due to the phosphorylation of hWRN-p 
by DNA-PKCS in the presence of Ku heterodimer (Karmakar et al., 2002a).  
The WRN exonuclease is strongly stimulated by Ku70/80, but the helicase and ATPase 
activities remain unaffected (Cooper et al., 2000). The stimulation requires both Ku70 and 
Ku80 (Li and Comai, 2000). Ku70/80 binds N-terminal and C-terminal domain of hWRN-p 
(Li and Comai, 2000, 2001; Karmakar et al., 2002b). The presence of Ku70/80 alters the 
substrate specificity of WRN exonuclease. The WRN exonuclease is not only stimulated on 
the usual 3’-recessed DNA substrate, but it can also cleave substrates previously 
unhydrolyzable, such as blunt-ended or 3’-protruding DNA (Li and Comai, 2000). 
Furthermore, this stimulation is seen with 1-388 aa N-terminal fragment of hWRN-p. A 
degradation of single-stranded DNA by this fragment has been described (Li and Comai, 
2001). The Ku heterodimer facilitates digestion also through regions containing 8-oxoadenine 
and 8-oxoguanine modifications (Orren et al., 2001).  
 
1.5.3.4. DNA polymerase β 
The DNA polymerase β is a protein involved in both short- and long-patch base excision 
repair (BER). This repair pathway removes DNA damages, such as deaminated, oxidized, 
alkylated and fragmented bases with the help of several proteins (Wilson and Thompson, 
1997). It has been shown that DNA polymerase β interacts with the C-terminal part of 
hWRN-p and has no effect on hWRN-p activities. On the contrary, hWRN-p stimulates a 




helicase activity. Interestingly, the WRN helicase can unwind a BER substrate, an 
oligonucleotide containing a nick, in the presence of an uracil-DNA glycosylase and an 
apurinic/apyrimidinic endonuclease. The data suggest, that hWRN-p may participate in long-
patch BER (Harrigan et al., 2003).  
 
1.5.3.5. Bloom syndrome protein 
The human Bloom syndrome protein (hBLM-p) belongs also to the RecQ family of helicases 
(see 1.2.1. and Figure 2) and displays structure-specific 3’  5’ helicase activity similar to 
that of the Werner syndrome protein (Brosh et al., 2001a; Karow et al., 1997, 2000; 
Mohaghegh et al., 2001; Sun et al., 1998). The interaction beween hWRN-p and hBLM-p is 
direct and is mediated by both N-terminal and RecQ family C-terminal domains.The binding 
of hBLM-p to the N-terminus of hWRN-p (aa 1-120) inhibits the WRN exonuclease activity. 
No synergistic unwinding by hWRN-p and hBLM-p has been observed (von Kobbe et al., 
2002). 
 
1.5.4. Other proteins 
1.5.4.1. Protein kinase A 
Cyclic 3'-5' adenosine monophosphate (cAMP) dependent protein kinase A (PKA) is an 
important enzyme in signal transduction. The enzyme is composed from two regulatory (R) 
and two catalytic (C) subunits. In the absence of cAMP the regulatory subunits are bound to 
the active site of the catalytic subunits, inactivating them. When cAMP is present, it binds to 
the regulatory subunits releasing the two catalytic subunits in an active stage. In dividing cells 
the human Werner syndrome protein is localized in the nucleolus. An increased level of 
cAMP or an expression of the regulatory subunit RIβ of PKA inhibits the nuclear 
redistribution of hWRN-p caused by serum withdrawal. Moreover, direct interaction of 





1.5.4.2. Ubc9 and SUMO-1 
The degradation of many proteins is mediated by ubiquitilation – a conjugation of ubiquitin to 
other cellular proteins. Ubiquitin is a highly conserved protein of 76 amino acids. The 
ubiquitin-conjugating enzyme Ubc9 is involved in the conjugation of an ubiquitin-related 
protein so called small ubiquitin-like modifier SUMO-1 (Pichler and Melchior, 2002; Tatham 
et al., 2003). The two hybrid analysis revealed that the mouse Werner syndrome protein 
interacts directly with Ubc9, which mediates further the interaction with SUMO-1. 
Furthermore, the hWRN-p has been found to be covalently associated with SUMO-1 


















1.6. Pathways in which the Werner syndrome protein may participate 
The biochemical characterization of WRN-p and the growing evidence of interactions 
between the Werner syndrome protein and other proteins involved in various pathways of 
DNA metabolism suggests that the WRN-p may participate in these processes. The putative 
pathways, in which the WRN-p may take a part are summarized in Figure 10. 
 
 
Fig. 10. Possible pathways, where the Werner syndrome protein may participate. The WRN-
p-interacting proteins are written in the bubbles together with the name of the pathway (in 
bold black characters), in which they are involved. BER-LP: Base excision repair – long 






2. Aim of the work 
The isolation and characterization of factors involved in DNA recombination and DNA repair 
from Arabidopsis thaliana allows us to understand the biological functions of such proteins in 
plants.  
The intention of this study was the characterization of the Werner syndrome exonuclease 
homologue (AtWRNexo-p) from Arabidopsis thaliana. The first goal was to establish the 
molecular structure of the AtWRNexo gene. The second goal was to determine the activity 
and substrate specificity of AtWRNexo-p and compare it to the exonuclease activity of human 






















3.1. Escherichia coli strains 
DH5α:  recA1, endA1, gyrA96, thi-1, hsdR17, (rK-mK+),                  Gibco BRL, Eggenstein 
             relA1, supE44, [u80∆lacZ∆M15, Tn10, (Tetr)]c               
BL21(DE3) : B F- dcm ompT hsdS(rB-mB-) gal λ (DE3)                     Novagen, Madison, USA 
 
3.2. Saccharomyces cerevisiae strains 
Y190: MATa, ura3-52, his3-200, ade2-101, lys2-801, trp1-901,        Clontech, Heidelberg 
           leu2-3, 112, gal4∆, gal80∆, cyhr2,  
           LYS2::GAL1UAS-HIS3TATA-HIS3, MEL1 
           URA3::GAL1UAS-GAL1TATA-lacZ 
EGY48: MATα, ura3, his3, trp1, LexAop(x6)-LEU2                             Clontech, Heidelberg 
 
3.3. Plasmids 
pCAL-n-FLAG                             Ampr  (Stratagene) 
pGILDA                                        Ampr, HIS3  (Clontech) 
pB42AD                                        Ampr, TRP1  (Clontech) 
p8oplacZ                                       Ampr, URA3  (Clontech) 
pGAD GH                                     Ampr, LEU2  (Clontech) 
pAS2-1                                          Ampr, TRP1  (Clontech)      
 
3.4. Clones for two-hybrid systems 
AtRecQl1/pAS2-1, AtRecQl2/pAS2-1, AtRecQl3/pAS2-1, obtained from Dr. Frank Hartung 
AtWRNexo/pGAD GH 




AtMLH1/pGILDA, AtKu70/pB42AD, AtRad51/pB42AD,  
 AtUbc9/pB42AD, AtMLH1/pB42AD 
 
3.5. Primers and oligonucleotides 
Primers for amplification of AtWRNexo ORF for cloning into pCAL-n-FLAG: 
HP40      5’ - GACGACGACAAGATGTCATCGTCAAATTGGATC – 3’ 
HP41      5’ – GGAACAAGACCCGTTTATGAGCCACTGACAGCA – 3’ 
Primers for amplification of AtWRNexo ORF for cloning into pAS2-1: 
HP21                      5’ - CAT GGA ATT CAT GTC ATC GTC AAA TTG G – 3’ 
WRN-Sal1-AS21   5’ - ACG CGT CGA CTT ATG AGC CAC TGA CAG – 3’ 
Primers for amplification of AtWRNexo ORF for cloning into pGILDA and pB42AD: 
HP21                      5’ - CAT GGA ATT CAT GTC ATC GTC AAA TTG G – 3’ 
HP22                      5’ - CGA ACT CGA GTT ATG AGC CAC TGA CAG C – 3’ 
Primers for introduction of a mutation into AtWRNexo ORF: 
HP150                    5’ - GTT GGC TTG GAT ATT GCG TGG AGA CCA AGT TTT AG – 3’ 
HP151                    5’- CTA AAA CTT GGT CTC CAC GCA ATA TCC AAG CCA AC – 3’ 
Primers for amplification of ORFs of AtWRNexo interaction partners: 
AtRecQl1 for cloning into pGILDA: 
RQ5-5S-Xma1 5’- ACT ATC CCG GGG ATG AAG GAT CAA GAT C-3’ 
RQ5-3S-BamH1 5’-GCT AGG GAT CCT CAG CTT CTT TCA CAG T-3’ 
AtRecQl3 for cloning into pGILDA: 
HP7 5’-ACG CCT CGA GAT GAA GAA ATC GCC G-3’ 
HP59 5’-ACG CCT CGA GTT ATT GAA GCT TCA TTA TCT T-3’ 
AtRecQl4a for cloning into pGILDA: 
RQl2-5S-Xma1 5’-GCT ATC CCG GGT ATG AGT AGG AGT CAC C-3’ 




AtRecQl5 for cloning into pGILDA: 
HP69 5’-GCT AGG GAT CCG TAT GAC GTC TTC TTC C-3’ 
HP70 5’-CGA ACT CGA GTT ATG TAG CTA AAG CTG-3’ 
AtRecQsim (First half) for cloning into pGILDA: 
RQ3-5S(XmaI) 5’-GCT ATC CCG GGT ATG GAT TTG TCT TCT G-3’ 
HP60 5’-ACG CGC TAG CTT TTT CCC G-3’ 
AtRecQsim (Second half) for cloning into pGILDA: 
HP61 5’-ACG CGC TAG CAG TAA TCT CA-3’ 
RQ3-3S(XhoI) 5’-CGA ACT CGA GTT ATT CTT TGC TTC TCC-3’ 
AtKu80 for cloning into pGILDA: 
HP79 5’-CAT GGA ATT CAT GGC ACG AAA TCG G-3’ 
HP80 5’-GCT AGG GAT CCT TAG CTC TCG AGC ATT-3’ 
AtKu80 for cloning into pB42AD: 
HP79 5’-CAT GGA ATT CAT GGC ACG AAA TCG G-3’ 
HP81 5’-CAT GGA ATT CTT AGC TCT CGA GCA TT-3’ 
Primers for PCR screening: 
PCAL-n-FLAG: 
pET3-18mer            5’-CTAGTTATTGCTCAGCGG-3’ 
pCAL-n5-21mer     5’-GAATTTCATAGCCGTCTCAGC-3’ 
pAS2-1: 
pAS 2-1 up               5’-CAT CGG AAG AGA GTA GTA AC-3’ 
pAS 2-1 down          5’-AGC GAC CTC ATG CTA TAC C -3’             
pGILDA 
HP9                          5’-GTCAGCAGAGCTTCACCATT-3’ 





HP11                        5’-CAGCCTCTTGCTGAGTGGA-3’ 
HP12                        5’-CGTATCTACCAACGATTTGAC-3’ 
Primers for sequencing: 
AtRecQl1: 
RQ5-1 5’-CAT TGG ATG ATC TTG AAT TTG-3’ 
RQ5-R4 5’-CCT GGT AAC ACA AAC TTT TCC-3’ 
RQ5-R2 5’-CTT GAA GCC CGT CCC TTC-3’ 
AtRecQl3: 
BL4 5’-CAA CCT GTG ATG ACT TGT CT-3’ 
RQ1-5 5’-GAA GGT TCT GGA TGC CGA AG-3’ 
BLrev2 5’-GCT CAT CTC TGC TTG CGG T-3’ 
BLrev5 5’-ACA GTA CTC CTC ATT TTA CT-3’ 
AtRecQl4a: 
RQL2-(-3)  5’-AGT GCA ATG AAT GTT TCA GG-3’ 
RQL2-(-1) 5’-GCA GCT CGA GAA CCA TAT CC-3’ 
RQL2-2 5’-TTC GAC CTA ACC AGA GAG AA-3’ 
RQL2-3 5’-GAT GAA GCT CAT TGT GTG AG-3’ 
RQL2-4 5’-GCC TGA TGT CCG CTT TGT TA-3’ 
RQL2-R1 5’-CCA AGG CCA TTG ATT TCA AG-3’ 
RQL2-R3 5’-ACT ACT CAA CAA TTA TCA CAC-3’ 
RQL2-R6 5’-AAT AAG AGA CAC AAG TGG AGA-3’ 
RQL2-R7 5’-TAG ATT CGA ACT GCT CAG CTG-3’ 
AtRecQl5: 
RQ7-1a 5’-GAA CTT AAA TGG CAA GAG AGG-3’ 
RQ7-1 5’-ATG GTG TTT CGT AGC AAC G-3’ 




RQ7-3 5’-GAC TTG ACA AGG GAG ATG TAG-3’ 
RQ7-4 5’-GCG GTT GTC ATA TTG TCA TCT C-3’ 
RQ7-R1 5’-CAA CTC CGT GCA TTA TTC TC-3’ 
RQ7-R2 5’-GTG TGC AAG ACT CCG AAG C-3’ 
AtRecQsim: 
RQ3-1a 5’-GTC GTA ATT TCG CCT TTG AT-3’ 
RQ3-2 5’-GAG CTG GAA GAG ATG GCG-3’ 
RQ3-3 5’-GAA CAC TTC ACA ATG TCG G-3’ 
RQ3-R1 5’-GAA CTA AAT TCC TCC CCA AAG-3’ 
RQ3-R2 5’-CAA TGC GCT TCA TCA ATT GC-3’ 
RQ3-R1a 5’-CGC CAT CTC TTC CAG CTC-3’ 
AtKu80: 
Ku80-2 5’-AGT ATG ATG AAG TTG GAA TTG-3’ 
Ku80-R1 5’-ATT GGG TTT GCA TCT CCG AC-3’ 
Ku80-R2 5’-GTG GGA AGT CTC TCC TCA G-3’ 
 
Oligonucleotides for the exonuclease assays: 
     Oligo No.                     Name                                                                          Nucleotide sequence 
1 20merT 5’-CGCTAGCAATATTCTGCAGC-3’ 
2 19merNP 5’-Pho-CGCTAGCAATATTCTGCAG-3’ 
3 46merT 5’-TTTTTTTTTTTTTGCTGCAGAATATTGCTAGCGTTTTTTTTTTTTT-3’ 
4 T21 5’-TTTTTTTTTTTTTTTTTTTTT-3’ 
5 BLU1 5’-CGCTAGCAATATTTTTTTTTTTT-3’ 
6 BLU2 5’-AAAAAAAAAAAATATTGCTAGCG-3’ 
7 HPO1 5’-TGACGTGACGACGATCAGGGTACGTTCAGCAG-3’ 
8 OL11LATER 5’-TGACGTGACGAC(8-oxoG)ATCAGGGTACGTTCAGCAG-3’ 
9 OL12LATER 5’-TGACGTGACGACG(8-oxoA)TCAGGGTACGTTCAGCAG-3’ 
10 OL13 5’-TGACGTGACGACGATCAGGGTACGT(dU)CAGCAG-3’ 
11 OL14 5’-AGTGCAGACTGCTGCTGAACGTACCCTGATCGTCGTCACGTCA-3’ 
12 ANOK 5’-CGCGCCGAATTCCCGCTAGCAAT-3’ 
13 AN-1 5’-CGCGCCGAATTCCCGCTAGCAATG-3’ 
14 AN-2 5’-CGCGCCGAATTCCCGCTAGCAATGC-3’ 
15 D1 5’-GCGCGGAAGCTTGGCTGCAGAATATTGCTAGCGGGAATTCGGCGCG-3’ 




17 ABAS 5’-TGACGTGACGACGATCAGGGTAC(ABAS)TTCAGCAG-3’ 
18 CHOLE 5’-TGACGTGACGACGATCAGGGTAC(CHOLE)TTCAGCAG-3’ 
19 ETAD 5’-TGACGTGACGACGATCAGGGT(ETAD)CGTTCAGCAG-3’ 
20 HYPO 5’-TGACGTGACGACGATCAGGGT(HYPO)CGTTCAGCAG-3’ 
21 20merNP 5’-CGCTAGCAATATTCTGCAGC-3’ 
22 20merR 5’- CGCUAGCAAUAUUCUGCAGC-3’ 
23 46merR 5’-UUUUUUUUUUUUUGCUGCAGAAUAUUGCUAGCGUUUUUUUUUUUUU-3’ 
Oligos 8, 9, 17, 18, 19 and 20 carry a DNA modification: 8-oxoG (8-oxoguanine), 8-oxoA (8-
oxoadenine), ABAS (abasic site), CHOLE (cholesterol), ETAD (ethenoadenine), HYPO 
(hypoxanthine). “Pho” in oligonucleotide  2 indicates a phosphate group on the 5’-end. 
 
3.6. DNA, proteins, systems and kits 
Smart – ladder Eurogentec, Seraing, Belgium  
Oligonucleotide sizing markers Amersham, Braunschweig 
SigmaMarker High Range Sigma, München 
PfuTurbo DNA polymerase Stratagene, Heidelberg 
Bacteriophage T4 Polynucleotide kinase New England Biolabs, Beverly, MA 
Klenow fragment of E. coli DNA polymerase I New England Biolabs, Beverly, MA 
Lysozyme Roche, Mannheim 
ExTaq Polymerase TaKaRa, Alpen 
Qiaex II kit, Qiagen Plasmid Isolation Kit Qiagen, Hilden 
QuikChange Site-Directed Mutagenesis Kit Stratagene, Heidelberg 
MATCHMAKER Two-Hybrid System 2 Clontech, Heidelberg 
MATCHMAKER LexA Two-Hybrid System Clontech, Heidelberg 
Affinity LIC Cloning and Protein Purification Kit Stratagene, Heidelberg 
High Pure PCR Product Purification Kit Roche, Mannheim 
ABI PrismTM DNA Sequencing Kit Applied Biosystems, Weiterstadt 
 
3.7. Chemicals 





Benzamidine, Leupeptine, 4-(2-aminoethyl) Sigma, München 
benzenesulfonyl fluoride hydrochloride (AEBSF), 
D(+) Galactose (<0,01% glucose), 3-amino- 
1, 2, 4-triazole (3-AT), Triton X-100 
[γ−32P]ATP, [α-32P]dCTP Amersham, Braunschweig 
Adenosine 5 -[γ-thio]triphosphate (ATPγS) 
Ammonium persulphate, (TEMED) Bio-Rad, München; AGS Heidelberg 
Urea 
D(+) Raffinose pentahydrate, Dithiothreitol Fluka, Deisenhofen 
(DTT), N,N-dimethylformamide (DMF), Glu- 
cose, Disodium hydrogenphosphate heptahydrate, 
Adenosine triphosphate (ATP), Caseine 
 hydrolysate, Lithium acetate dihydrate,  
Ammonium sulphate 
Bacto agar, Yeast nitrogen base (YNB) Difco, Detroit, MI, USA  
Peptone 140 selected Gibco BRL, Eggenstein 
Yeast extract Servabacter, β-mercaptoetha- Serva, Heidelberg 
nol, Zink chloride, Manganese (II) chloride 
tetrahydrate, Ethidiumbromide 
Tryptone, Carbenicillin Duchefa, Haarlem, NL 
Drop out (DO) Supplements: -Ura, -Trp, Clontech, Heidelberg 
-Leu, -Ura/-Trp, -His/-Ura, -Leu/-Trp, 
- His/-Trp/-Ura, -His/-Trp/-Leu, -His/-Trp/ 





Sodium chloride, Sodium dihydrogenphosphate, Roth, Karlsruhe 
monohydrate, Glycerol, 5-bromo-4-chloro-3-indolyl 
-β-D-galactopyranoside (X-gal), Polyethylene glycol  
(PEG 3350), Calcium chloride, Tris, Sodium 
hydroxide, Hydrogenchloride, Potassium chloride 
Magnesium chloride, Bovine serum albumin (BSA) New England Biolabs, Beverly, MA 
Magnesium sulphate heptahydrate Merck, Haar 
Agarose (Sea-Kem) Biozym, Hessisch. Oldendorf 
 
3.8. Consumed material 
MicroSpinTM G-50 Sepharose columns Amersham, Braunschweig 
Gel temperature indicator, Ready gel Bio-Rad, München; AGS Heidelberg 
(10 well Tris-HCl, 10%), Ready gel (10 
well TBE, 15%), Poly-Prep Chromato- 
graphy columns 
Gel sealing tape Gibco BRL, Eggenstein 
Blue Slick Serva, Heidelberg 
Rotiszint®eco plus, Mini Vials C Roth, Karlsruhe 
Whatman 3MM-filter paper Bender&Hobein, Karlsruhe 
 
3.9. Laboratory tools 
Mini-Wipptisch WT Biometra, Göttingen 
Sonopuls HD2070, Lärmschutzbox LS5 Schütt, Göttingen 
Edelstahl (Hubtisch) 





DNA Gel-electrophoresis tanks Bio-Rad, München; AGS Heidelberg 
Spectrophotometer Spectronic 1201 Milton Roy, Rochester, NY, USA 
pH-meter Hanna-Hi 9321 Schütt, Göttingen  
Shaker (Vortex Genie 2TM), Megafuge 1.0R Heraeus, Osterode 
ABI PRISM DNA sequencer, WINSpectal Perkin Elmer, Wellesley, USA 
WALLAC LSC, Perkin Elmer Gene Amp PCR 
System 2400 
Waterbath Haake, Karlsruhe 
Weight Sartorius, Göttingen 
Centrifuge 5415 R, Thermomixer 5436 Eppendorf, Hamburg 
Gel-drier Model PH-t 60 Biotec-Fischer, Reiskirchen 
 
3.10. Media, buffers and solutions 
Bio-Safe Coomassie Stain, Nucleic Acid Bio-Rad, München; AGS Heidelberg 
Sample Loading Buffer, 5X TBE-Urea  
Sample Buffer, Laemmli Sample Buffer, 
10X Tris/Glycine/SDS Buffer, 10X TBE 
Buffer, Acrylamide and Bis-Acrylamide 
solutions, Protein assay 
 
Carbenicillin 50mg/ml H2O 
LB broth 10g NaCl, 10g Tryptone, 5g Yeast extract for 1l (pH 7.0)  
LB-carbenicillin broth LB broth, 100µg/ml carbenicillin (pH 7.0) 
LB-Carbenicillin Agar LB broth, 20g agar, 100µg/ml carbenicillin (pH 7.0) 




                                 6H2O, 3g MgSO4.7H2O, 4g Glucose 
SOC medium 20g Tryptone, 5g Yeast extract, 0.5g NaCl, 2g MgCl2.6H2O, 
               2.5g MgSO4.7H2O, 4g Glucose 
CaCl2 binding buffer  750mM NaCl, 50mM Tris-HCl, pH 8.0, 2mM CaCl2, 
                  0.1% Triton X-100, 10mM ß-mercaptoethanol  
Washing buffer 1 750mM NaCl, 50mM Tris-HCl, pH 8.0, 2mM CaCl2, 
                          10mM ß- mercaptoethanol 
Washing buffer 2 500mM NaCl, 50mM Tris-HCl, pH 8.0, 2mM CaCl2, 
              10mM ß-mercaptoethanol 
Elution buffer 500mM NaCl, 50mM Tris-HCl, pH 8.0, 2mM EGTA, 
                     10mM ß-mercaptoethanol 
Protease inhibitors: 
1000X Leupeptine 2mg/ml H2O 
100mM Benzamidine 1.57mg/ml H2O 
420X AEBSF 50mg/ml H2O 
In the protein isolation procedure the final working concentrations were 2µg/ml leupeptine, 
1mM benzamidine and 0.1mg/ml AEBSF. 
Reaction buffer 1 40mM Tris-HCl, pH 8.0, 4mM MgCl2, 5mM dithiothreitol, 
                 1mM  ATP, and 0.1mg/ml bovine serum albumine 
Reaction buffer 2 40mM Tris-HCl, pH 7.4, 4mM MgCl2, 5mM dithiothreitol, 
            1mM  ATP, and 0.1mg/ml bovine serum albumine 
Solutions for Two-hybrid assays: 
10X glucose(20%) 22g glucose monohydrate/100ml H2O 
10X (NH4)2SO4 5g /100ml H2O 
10X YNB 1,7g /100ml H2O 




125X adenine sulphate 5mg/ml 
1M LiAc 20.4g LiAc.2H2O/ 200ml H2O, adjust pH 7.5 with diluted acetic 
                         acid 
2mg/ml carrier DNA add 200 µl carrier DNA (10mg/ml) to 800 µl H2O, heat 5 min 
                     at 100°C and put quickly on ice 
50% (w/v) PEG 3350 40g /80ml H2O 
X-gal        20mg /ml DMF 
10X BU salts (1l) 30.8g Na2HPO4.2H2O  
                     39.66g NaH2PO4.H2O, adjust pH 7 with NaOH lens  
5X galactose (10%) 100g /l H2O 
20X raffinose (20%) 23.6g raffinose pentahydrate/100ml H2O 
1M 3-amino-1, 2, 4-triazole (3-AT)  
Z-buffer (1l) 16.1g Na2HPO4.7H2O, 5.5g NaH2PO4.H2O, 0.75g KCl,  
                   0.246g MgSO4.7H2O 
Z/X-buffer 100ml Z-buffer, 0.27ml β-mercaptoethanol, 1.67ml X-gal 
Mediums for yeast transformation: 
YPAD (1l) 10g Yeast extract, 20g Peptone, 100ml 10x glucose,  
                    4 ml 125X adenine sulphate 
DO liquid medium (1l) 100ml 10X glucose, 100ml 10X (NH4)2SO4, 100ml 10X YNB, 
                 100ml 10X DO, rest H2O   
DO medium/ agar (1l) DO liquid medium, 20g agar 
Mediums for GAL4 protein-protein interaction assay: 
DO/3-AT (1l) 100ml 10X glucose, 100ml 10X (NH4)2SO4, 25ml 1M 3-AT, 
                    100ml 10X YNB, 100ml 10X DO, rest H2O 
        (DO = -Trp/-Leu/-His) 




DO/X-gal/BU salts (1l) 100ml 10X glucose, 100ml 10X (NH4)2SO4, 100ml 10X YNB, 
                  100ml 10X DO, 100ml 10X BU salts, 4ml X-gal, rest H2O 
                   (DO = -Ura/-His/-Trp or -Ura/-His/-Trp/-Leu) 
DO/galactose/raffinose (1l) 200ml 5X galactose, 50ml 20X raffinose, 100ml 10X YNB, 
                  100ml 10X (NH4)2SO4, 100ml 10X DO, rest H2O 
                (DO = -Ura/-His/-Trp/-Leu) 
DO/X-gal/BU salts/galactose/raffinose (1l) 200ml 5X galactose, 50ml 20X raffinose, 100ml 
                           10X YNB, 100ml 10X (NH4)2SO4, 4ml X-gal, 
                                    100ml 10X DO, rest H2O, 100ml 10X BU salts  
                                     (DO = -Ura/-His/-Trp or -Ura/-His/-Trp/-Leu) 
 
3.11. Software 
The DNA and protein sequence data were processed using the program “DNA-star”. The 

















4.1. Cloning of AtWRNexo into vectors for protein expression and two-
hybrid assay 
The AtWRNexo open reading frame (ORF) was amplified using the PfuTurbo DNA 
polymerase and combination of primers HP40/HP41 (for pCAL-n-FLAG), HP21/WRN-Sal1-
AS21 (for pAS2-1) and HP21/HP22 (for pGILDA and pB42AD). The plasmid pGAD GH 
containing the AtWRNexo ORF (obtained by Dr. Frank Hartung) was used as a template in 
the amplification reaction. For the amplification of AtWRNexo to clone it into the two-hybrid 
vectors, following PCR program was run: 5’ 95°C; 5X: 20’’ 95°C/15’’ 50°C/1’ 72°C; 20X: 
20’’ 95°C/15’’ 60°C/1’ 72°C; 2’ 72°C; 4°C. The amplified products were purified using the 
High Pure PCR Product Purification Kit according to the manufacturer. The following gel 
electrophoresis, restriction and ligation were performed according to Sambrook et al, 1989. 
The transformation of E. coli (DH5α) was done using the heat shock procedure. The E. coli 
cells carrying the plasmid were selected on LB-carbenicillin plates. The amplification of 
AtWRNexo for the expression vector was done by following PCR program: 5’ 95°C; 17X: 
20’’ 95°C/15’’ 56°C/1’ 72°C; 2’ 72°C; 4°C. The PCR product was then purified using the 
High Pure PCR Product Purification Kit according to the manufacturer and cloned into the 
pCAL-n-FLAG vector using the Affinity LIC Cloning and Protein Purification Kit. The 
ligation-independent cloning (LIC) method doesn’t need any restriction or ligation enzymes 
(Figure 11). The LIC reaction was then transformed into Epicurian Coli SoloPack Gold cells 
as described in the manufacturer’s protocol. The positive clones (both for the protein 
expression and for the two-hybrid system) were identified by PCR screening using the 
primers for the respective vector. The amplified products were sequenced using PCR 




with the “DNA-star” software and the plasmid DNA (pCAL-n-FLAG-AtWRNexo) was 
isolated using Qiagen Plasmid Isolation Kit.  
 
ig. 11. Ligation independent cloning of the protein – coding sequence to produce CBP-
FLAG fusion proteins. PCR primers are engineered to include the 5’ end vector specific 
 
F
sequence shown in the figure. The sequence of interest is than amplified by PCR. Treatment 
of the DNA with Pfu DNA polymerase and dATP results in a degradation of the 3’ ends until 
the first adenine base (A) is reached (the DNA is cleaved also in the inserted sequence of 
interest). The treated PCR fragment is annealed to the single-stranded overhangs (12- and 13-
nts) of the pCAL-n-FLAG vector (this vector is restriction-digested and pretreated with Pfu 
DNA polymerase in the presence of dTTP) and the single-stranded gap is repaired in vivo 






4.2. Production of pCAL-n-FLAG-AtWRNexoE135A 
duced by the QuikChange 
PfuTurbo DNA polymerase and a temperature cycler. The 
The point mutation E135A (Glu Ala at amino acid 135) was intro
Site-Directed Mutagenesis Kit according to the manufacturer’s protocol using primers HP150 
and HP151, carrying the mutation. 
 This method was performed using 
PCR mixture containing the plasmid pCAL-n-FLAG with inserted AtWRNexo ORF was 
given into the thermal cycler and following PCR program was run: 30’’ 95°C; 12X: 30’’ 
95°C/1’ 60°C/14’ 68°C; 4°C. The incorporation of the mutated primers generated a mutated 
plasmid (pCAL-n-FLAG-AtWRNexoE135A) containing nicks. The parental methylated DNA 
(DNA isolated from almost all Escherichia coli strains is dam methylated) was then digested 
with endonuclease Dpn I, which is specific for methylated and hemimethylated DNA. The 
nicked vector DNA containing the desired mutation was transformed into XL1-Blue 
supercompetent cells, which repaired the nick. The cells were propagated on LB-carbenicillin 
plates. The positive clones were identified by PCR screening. The amplified products were 
then sequenced using PCR screening primers and ABI PRISM DNA sequencer. Mutation-free 
clones were identified with the “DNA-star” software and the plasmid DNA was isolated using 
Qiagen Plasmid Isolation Kit.  
 
4.3. Expression and purification of AtWRNexo-p and AtWRNexoE135A-p 
 
carbenicillin broth was inoculated with 1 ml of the cells. The cells were grown at 37°C till 
The pCAL-n-FLAG-AtWRNexo and pCAL-n-FLAG-AtWRNexoE135A were transformed
into the E. coli protein expression strain BL21(DE3) from Novagen according to the 
Novagen’s protocol and propagated on the LB-carbenicillin plates. 5 ml of LB-carbenicillin 
broth was then inoculated with a single colony and was grown at 37°C till the optical density 
OD600 of 0.6-1.0 was reached. The culture was centrifuged at 6000 x rpm for 15 minutes at 




OD600 of 0.6-1.0. After a centrifugation at 6000 x rpm for 15 minutes at 4°C the LB-
carbenicillin medium was replaced again. The CBP-FLAG-AtWRNexo protein was then 
overexpressed by 1mM isopropyl-β-D-thiogalactopyranoside induction for 6h at 25°C. After 
the induction, the cells with the expressed protein were centrifuged at 4000 x rpm for 30 
minutes at 4°C and after the removal of the medium were frozen in a liquid nitrogene and 
stored at -80°C until further use. The purification procedure followed the instructions of 
Affinity LIC Cloning and Protein Purification Kit manufacturer with some modifications. The 
frozen cells were thawed and resuspended in CaCl2 binding buffer (5ml/g) and a mixture of 
protease inhibitors (leupeptine, benzamidine, AEBSF). Lysozyme (200µg/ml) was added and 
the suspension was incubated with gently shaking on ice for 20 minutes. The cells were 
further disrupted by sonication and centrifuged at 13000 x rpm for 20 minutes at 4°C. The 
lysate was then put on a 2ml-CaM-resin PolyPrep Chromatography column equilibrated in 
CaCl2 binding buffer. The column was extensively washed with ten volumes of CaCl2 binding 
buffer and two volumes of washing buffers 1 and 2 supplemented with proteases inhibitors. 
Proteins were eluted in elution buffer. Elution fractions of 0.5 ml were collected and analysed 
by SDS-PAGE. The protein concentration was determined by the Bradford assay using 
bovine serum albumine (BSA) as a standard. The purified AtWRNexo-p was supplemented 
with 100µg/ml BSA and stored in elution buffer containing 25% glycerol in 20 µl aliquots at -
80°C. The activity of AtWRNexo-p remained stable for at least 6 months. AtWRNexoE135A-
p was expressed and purified in an identical fashion as used for AtWRNexo-p. 
 
4.4. Oligomers labeling and substrate preparation 
Single-stranded DNA and RNA oligomers (7 pmol) were 5’-end-labeled with [γ-32P]ATP 
(3000 Ci/mmol) using T4 polynucleotide kinase according to the manufacturer. The 








Table below marked with asterisk) were annealed to the complementary strand in a 1:2 molar 
ratio in 70mM Tris-HCl buffer, pH 7.6, 10mM MgCl2 by incubation at 95°C for 5 min and 
then slow cooling to room temperature. The 3’-end-labeled substrate was produced by the 
annealing of 19-mer DNA (19merNP) to the 46-mer (46merT) oligonucleotide (1:2) and 
labeling the 3’-end of 19-mer using [α- P]dCTP and Klenow fragment of E. coli DNA 
polymerase I according to the manufacturer. Unincorporated labeled nucleotides were 
removed from labeling reactions using MicroSpin  G-50 columns. DNA substrates were 
stored at 4°C. RNA substrates were stored at – 20°C. 
 
 
DNA and RNA substrates used in this study 




*1 + 3 
 
*12 + 15 
              
 *3 + 1 
 
*13 + 15 
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4.5. DNA and RNA substrates concentration determination 
The DNA substrate (1µl) was mixed with 4ml of scintilation liquid Rotiszint®eco plus and 
analyzed by WINSpectal liquid scintillation counter. From measured counts per minute 
PM), the concentration of DNA substrate in terms of DNA molecules was calculated 





(a) The measured counts per minute (CPM) were recalculated to obtain decays per second 
f 1µl of [γ-32P]ATP (3.33 pmol) at the day of measurement (N) 
968 * 106 * e-0,0484615τ) / 86400  
 calibration 
nd corresponds to 31968 * 106 (DPD).  
ted under the assumption that N = N0/2 and a decay half time τ1/2 
were used to calculate the concentration (C) of the 
.6. Exonuclease assay 
plemented with respective cations was used as indicated in Figure 21. 
 DNA substrates (DNA amounts are expressed in terms of 
olecules) and AtWRNexo proteins used see figure legends. The reactions were performed at 
(DPS), which represent the real value of decays (normalized by an efficiency of measurement 
of the scintillation counter). 
DPS = CPM/ (60 * 0.9) = CPM/ 54  
The value 60 means 60 s. 
The value 0.9 is an efficiency of measurement (90%, experimentally determined). 
 
(b) The decays per second o
were calculated as follows.  
N = N0 * e-λτ / 86400 = (31
The value N0 represents decays per day (DPD) of 1µl of [γ-32P]ATP at the day of
a
τ is a time distance (in days) from the day of calibration. 
λ is a decay constant calcula
is 14.3 days.  
 
(c) The determined values DPS and N 
probes (in fmol/µl): 
C = (3.33 * DPS * 1000)/ N 
 
4
Reactions (10µl) were performed in reaction buffer 1, for investigation of cation requirements 
reaction buffer 2 sup





22°C for 1h, unless otherwise indicated and terminated by addition of an equal volume of 
-5S-XmaI/RQ5-3S-BamHI (for AtRecQl1 into 
GILDA), HP7/HP59 (for AtRecQl3 into pGILDA), RQl2-5S-XmaI/RQl2-3S-(BamHI) (for 
 into pGILDA) and HP79/HP81 (for AtKu80 into pB42AD). The plasmid pGEM-T 
denaturing loading buffer, immediately heated at 98°C for 3 min, analysed on 20% 
polyacrylamide 1XTBE - 7M urea gel using a Model S2 sequencing gel electrophoresis 
apparatus and visualized by autoradiography. 
 
4.7. Cloning of AtWRNexo interaction partners into vectors for two-hybrid 
assay 
ORFs of AtWRNexo interacting partners were amplified using the PfuTurbo DNA 
polymerase and combination of primers RQ5
p
AtRecQl4a into pGILDA), HP69/HP70 (for AtRecQl5 into pGILDA), HP79/HP80 (for 
AtKu80
containing the respective ORF (obtained by Dr. Frank Hartung) was used as a template in the 
amplification reaction. For the amplification following PCR program was run: 5’ 95°C; 5X: 
20’’ 95°C/15’’ 46°C/Y’ 72°C; 20X: 20’’ 95°C/15’’ 60°C/Y’ 72°C; 2’ 72°C; 4°C. “Y” 
indicates the time for amplification as follows: 4’ for the amplification of AtRecQl1, 
AtRecQl3, AtRecQl5 and AtKu80 and 8’ for the amplification of AtRecQ4a. The amplified 
products were purified using the High Pure PCR Product Purification Kit according to the 
manufacturer. The following gel electrophoresis, restriction and ligation were performed 
according to Sambrook et al, 1989. The transformation of E. coli (DH5α) was done using the 
heat shock procedure. The E. coli cells carrying the plasmid were selected on LB-carbenicillin 
plates.  
AtRecQsim was cloned into pGILDA using primers RQ3-5S(XmaI)/HP60 (for the first half 
of AtRecQsim) and HP61/RQ3-3S(XhoI) (for the second half of AtRecQsim). cDNA 




amplification following PCR program was run: 5’ 95°C; 5X: 20’’ 95°C/15’’ 46°C/2’ 72°C; 
20X: 20’’ 95°C/15’’ 60°C/2’ 72°C; 2’ 72°C; 4°C. The amplified products were purified using 
The identification of interacting partners with AtWRNexo protein was performed using the 
Two-Hybrid GAL4 and LexA System according to the protocols of the manufacturer. In 
GAL4 system, AtWRNexo fused to the activating domain was tested for the possible 
teractions with AtRecQl1, AtRecQl2 and AtRecQl3, which were fused to the DNA binding 
rank Hartung).  Single clones were transformed into Y190 yeast 
the High Pure PCR Product Purification Kit according to the manufacturer. The following gel 
electrophoresis, restriction and ligation were performed according to Sambrook et al, 1989. 
Both halfs containing common NheI restriction site were ligated together and cloned into the 
pGILDA plasmid. The transformation of E. coli (DH5α) was done using the heat shock 
procedure. The E. coli cells carrying the plasmid were selected on LB-carbenicillin plates.  
The positive clones were identified by PCR screening using the primers for the respective 
vector. The amplified products were sequenced using PCR screening primers, primers 
specific for the respective ORF and ABI PRISM DNA sequencer. The mutation free clones 
were identified with the “DNA-star” software and the plasmid DNA (pCAL-n-FLAG-
AtWRNexo) was isolated using Qiagen Plasmid Isolation Kit.  
 
4.8. Two-hybrid assay 
in
domain (obtained from Dr. F
strain via “Lazy bones” plasmid transformation procedure (Elble, 1992). The 
contransformation of both clones together was done following the High-efficiency 
transformation protocol (Gietz and Schiestl, 1995). After the transformation, the yeast cells 
carrying single clones were propagated on –Trp or –Leu plates, the double-transformants 
were grown on –Trp/-Leu plates at 28°C. To investigate the protein-protein interactions, the 




amino-1, 2, 4-triazole (3-AT)  to screen for an activation of HIS3 reporter gene. Additionally, 
an activation of the second reporter gene lacZ was tested by colony-lift filter assay according 
to the Clontech protocol. The clones were also tested for self-activation by growing on –His 
medium with 25mM 3-AT and by the same X-gal staining procedure. As a positive 
interaction control, SNF1 fused to the DNA binding domain and SNF4 fused to the activation 
domain was used.  
In the LexA system the interactions between AtWRNexo protein fused to the activation 
domain and AtRecQl1, AtRecQl3, AtRecQl4a, AtRecQl5, AtRecQsim, AtWRNexo, Ku80, 
Ku70, Ubc9, Rad51 and MLH1 proteins, which were fused to the DNA binding domain, were 
tested. Moreover, the AtWRNexo protein fused to the DNA binding domain and Ku80, Ku70, 
Ubc9, Rad51 and MLH1 protein bound to the activation domain were investigated. The yeast 
strain EGY48 was firstly transformed using High efficiency transformation procedure (Gietz 
and Schiestl, 1995) with the plasmid p8oplacZ carrying lacZ reporter gene. This yeast was 
then propagated on –Ura medium at 28°C. The single and double transformants were then 
obtained by transforming the EGY48/p8oplacZ with respective clones using the same 
transformation protocol. The single transformants were then plated either on –Ura/-His or on 
–Ura/-Trp medium and the double transformants on –Ura/-His/-Trp medium and let grow at 
28°C. To investigate the protein-protein interactions, double transformants were incubated at 
28°C on following mediums: –Ura/-His/-Trp/galactose/raffinose/X-gal/BU salts, –Ura/-His/-
Trp/-Leu/galactose/raffinose/X-gal/BU salts and –Ura/-His/-Trp/galactose/raffinose. An 
induction of expression of target proteins should take place only on medium containing 
galactose. If there is an interaction between tested proteins, the LEU2 and lacZ genes will be 
activated. As a positive control for interacting proteins the murine p53 protein fused to the 
DNA binding domain and SV40 large T-antigen fused to the activation domain were used. 
The clones were also tested for the self-activation by growing on –Ura/-




Ura/-His/-Leu/galactose/raffinose, -Ura/-Trp/galactose/raffinose/X-gal/BU salts, -Ura/-Trp/-
Leu/galactose/raffinose/X-gal/BU salts and -Ura/-Trp/-Leu/galactose/raffinose. That the 
positive interactions are a result of the expression of the tested proteins was checked by 
plating the transformed yeast on following plates containing glucose: –Ura/-His/X-gal/BU 
salts, –Ura/-His/-Leu/X-gal/BU salts, –Ura/-Trp/X-gal/BU salts, –Ura/-Trp/-Leu/X-gal/BU 

























.1. RecQ homologues from Arabidopsis thaliana 
 
even RecQ homologues have been identified in Arabidopsis thaliana by a database search 
sing homologies to known genes of other organisms (Hartung et al., 2000). Six of these 
amed RecQ-like (AtRecQl1, 2, 3, 4A, 4B and 5, respectively). The seventh one 
approximately 160 aa between 
groups according to their size. There are five RecQ proteins, which are small in size: 
AtRecQl1 (606 aa), AtRecQl2 (705 aa), AtRecQl3 (713 aa), AtRecQl5 (870 aa) and 





is named RecQsim (similar), because of an insertion of 
helicase domains III and IV. The schematic structure of the AtRecQ-like proteins is shown in 
Figure 12. 
 
Fig. 12. The schematic structure of the Arabidopsis thaliana RecQ proteins. The helicase 
domain with 8 conserved motifs and the HRDC domain is indicated. The insertion between 
the motif III and IV of the helicase domain by AtRecQsim is shown in red.  
 
The members of Arabidopsis thaliana RecQ family of helicases can be divided into two 





duplication. They are highly homologous with ~70% identity at both nucleic acid and protein 
level.  There has been, additionally to the usual RecQ domains, other domains in some RecQ 
proteins identified (Bagherieh-Najjar et al., 2003).  
 
5.2. WRN-like gene (AtWRNexo) 
The RecQ homologues are conserved across species. Surprisingly, using the homologies to 
the Werner syndrome protein, no gene encoding the complete homologue of WRN protein 
could be identified. Instead, a small gene (AtWRNexo) with a striking homology to only the 
xonuclease domain of human Werner syndrome protein has been detected. This gene is 
 any RecQ-like helicase domain. Further analysis 
 
 
Fig. 13. Schematic intron/exon structure of the Werner-like gene from Arabidopsis thaliana. 






present on chromosome 4 and is free of
revealed that AtWRNexo consists of six exons and encodes a protein with predicted 285 aa. 





5.3. WRN-like protein (AtWRNexo-p) 
An alternative splicing event of intron 5 in AtWRNexo results in production of two cDNAs. 
One cDNA corresponds to the protein of 285 aa. The second cDNA is 3 aa longer. The 







.3.1. The identification of the amino acid residues in AtWRNexo-p, critical 
84, 143D, 212Y and 216D. The comparison 








Fig. 14. The sequence of AtWRNexo gene products. The 3 extra amino acids present in the 
slightly longer Werner-like protein are depicted in red.   
 
5
for the exonucleolytic activity 
The amino acid sequence of the longer 288 aa AtWRNexo-p was compared with the N-
terminal part of the human Werner syndrome protein.  In human, the amino acids predicted to 
be critical for the exonuclease activity are D82, E
o
D194, Y263, D267 in the Arabidopsis thaliana sequence. All five residues lie within the 3
highly conserved motifs present in the exonuclease domain (see also Figure 3). The tota
identity between the N-terminus of the human WRN protein and AtWRNexo-p is 32% with 
similarity index of 45% (over 237 aa). At the far N-terminus AtWRNexo-p is 45 amino acid






WRNhuman MSEKKLETTAQQRKCPEWMNVQNKRCAVEE-RKACVRKSVFEDDLPFLEFTGSIVYSYDASD 61 
tWRNexo  TSVHGHEEDPNQIPNNIRRQLPRSITSSTSYKRFPLSR-CRARNFPAMRFGGRILYSKTATE 106 A
                                MOTIF 1    
WRNhuman CSFLSEDISMSL------SDGDVVGFDMEWPPLYNRGKL-GKVALIQLCVSESKCYLFHVSS 116  
                              M
AtWRNexo VDKRAMQLIKVLDTKRDESGIAFVGLDIAWRPSFRKGVLPGKVATVQICVDSNYCDVMHIFH 168 
OTIF 2                                           
WRNhuman MSVFPQGLKMLLENKAVKKAGVGIEGDQWKLLRDFDIKLKNFVELTDVANKKLKCTETWSLN 178 
AtWRNexo SGI-PQSLQHLIEDSTLVKVGIGIDGDSVKLFHDYGVSIKDVEDLSDLANQKIGGDKKWGLA 229 
                                          MOTIF 3                     
WRNhuman SLVKHLLGKQLLKDKSIRCSNWSKFPLTEDQKLYAATDAYAGFIIYRNLEILDDTVQRF 237 
Fig. 15. Amino acid sequence alignment of AtWRNexo-p with the N-terminus of the WRN 
of intron 5 of AtWRNexo gene are shown in bold black characters. Identical and conserved 
exonuclease domain are represented as gray shaded boxes. The five amino acids thought to be 
the exonucleolytic activity of AtWRNexo-p is shown in red.  
5.3.2. The construction of the CBP-tagg
AtWRNexo SLTETLVCKELLKPNRIRLGNWEFYPLSKQQLQYAATDAYASWHLYKVLKDLPDAVSGS 288 
 
protein from human. The three extra amino acids resulting from an alternative splicing event 
amino acids are shown in bold blue characters, highly conserved motifs within the 
critical for exonuclease activity are green shaded. The point mutation E135A that abolishes 
 
ed AtWRNexo-p and CBP-tagged 
tWRNexoE135A-p 
n ORF enc ing is la er versio of AtWRNe
of 
ny 
mutation and AtWRNexoE135A revealed only one desired codon substitution GAG to GCG 
A
A od  th rg n xo was cloned into a bacterial vector pCAL-
n-FLAG by ligation independent cloning (see Figure 11). A point mutation from glutamic 
acid to alanine at position 135 (E135A) corresponding to the am acid n  E84A, ino  cha ge
previously shown to eliminate exonuclease activity of the human WRN protein (Huang et al., 
1998), was introduced into the AtWRNexo ORF by site-directed PCR mutagenesis to 
generate pCAL-n-FLAG-AtWRNexoE135A. The sequences of cloned fragments 
AtWRNexo and AtWRNexoE135A were checked by sequencing. AtWRNexo was free of a
corresponding to the amino acid change E135A. The ORFs were inserted in frame into the 






Fig. 16. The schematic structure of the AtWRNexo protein. The protein is N-terminally fused 
antibody recognition site. The thrombin and enterokinase (EK) cleavage sites are indicated. 
 
5.3.3
to the calmodulin-binding peptide (CBP) purification tag followed by the FLAG epitope, an 
The whole tag comprises 41 aa and the tagged AtWRNexo protein is 329 aa in length. 
. Expression and purification of AtWRNexo-p and AtWRNexoE135A-p 
Recombinant proteins were overexpressed in E. coli and purified by one step CaM-affinity 
 
that might harm the protein. 
chromatography. The temperature is one of the factors determining whether the expressed 
protein will accumulate in inclusion bodies. The expression of AtWRNexo proteins was 
therefore performed at 25°C to enhance the fraction of soluble proteins. The small size of the 
4 kDa CBP affinity tag allows production of soluble target proteins of a larger size than those 
that are commonly achieved with glutathione S-transferase (GST, 26 kDa) or maltose-binding 
protein (MBP, 40kDa) and is also less likely to affect the function of the protein of interest. 
The CBP-tagged proteins bind to CaM resin in the presence of low concentrations of calcium
and elute in the presence of 2mM EGTA at neutral pH. The CBP-fusion is therefore an 




The purification procedure was optimized to reach the optimal purity of AtWRNexo proteins. 
Purified AtWRNexo-p and AtWRNexoE135A-p had a molecular weight of ~37kDa, as 
expected from the calculated one including the additional N-terminal 27 amino acids of the 
AtWRNexoE135A-p. Both proteins, AtWRNexo-p (lane 1) and AtWRNexoE135A-p (lane 3) 
graphy, electrophoresed 
(0.3µg) by 10% SDS-PAGE and stained with Bio-Safe Coomassie blue. Lane 2 represents 
molecular markers, positions of molecular size marker proteins are indicated. 
 
 
5.3.4. AtWRNexo-p has 3’  5’ exonuclease activity 
To determine whether AtWRNexo-p has an exonuclease activity, a duplex of an unlabeled 46-
mer DNA oligonucleotide annealed to either a 5’-32P-labeled 20-mer or 3’-32P-labeled 20-mer 
oligonucleotide was used. A constant amount of AtWRNexo-p (100 fmol) was incubated at 
CBP tag and 14 aa translated from the vector sequence (Figure 17).  
 












Fig. 17. SDS-PAGE analysis of bacterially expressed and purified AtWRNexo-p and 




22°C with each DNA substrate (200 fmol) for different periods of time. In a second 
eriment, the DNA substrates (200 fmol) with increasing amounts of AtWRNexo-p were 
cubated.  Digestion  of   5’-end  labeled   DNA   substrates  resulted  in  ladder-like  patterns  
ith labeled bands becoming progressively smaller with increasing incubation time and 
creasing enzyme concentration (Fig. 18, A and B). It was possible to observe an 
ccumulation of 2 – 6 nt fragments already after 15min of digestion. The size of the fragments 
ecame smaller (up to 2 nt) when incubation time was prolonged. When the DNA substrate 
as incubated with 500 – 2000 fmol of AtWRNexo-p for 1 h even a very weak band 
orresponding to mononucleotides was observed (Fig. 18B). Fragments of 3 – 6 nt could be 
e result of the fact that at this length the DNA duplex may dissociate under the conditions 
pplied yielding non-digestible single strands (see section 5. 3. 5.). 
 
Fig. 18. AtWRNexo-p hydrolyzes DNA in 3’  5’ direction. DNA substrates (200 fmol), 32P-
indicated periods of time (A) or with indicated amounts of AtWRNexo-p for 1h at 22°C (B). 
of DNA hydrolysis were resolved by electrophoresis on a 20% polyacrylamide – 7 M urea 
gel. The length of degraded fragments is indicated. It was determined using labeled DNA 











labeled at the 5’-end of 20-mer, were incubated with 100 fmol of AtWRNexo-p for the 




In contrast, incubation of AtWRNexo-p with a 3’-end labeled DNA substrate resulted, 
irrespective of the incubation time, besides the full-length substrate that disappeared with 
time, only in a single band migrating as a mononucleotide (Fig. 19, A and B). The intensity of 
degradation correlated with the amount of enzyme and the time of incubation. These data 
indicate, that AtWRNexo-p possesses no DNA endonuclease activity and acts under the 
applied conditions as an exonuclease digesting the DNA from the 3’ to 5’ end. 
 
Fig. 19. AtWRNexo-p hydrolyzes DNA in 3’  5’ direction. DNA substrates (200 fmol), 32P-
labeled at the 3’-end of 20-mer, were incubated with 100 fmol of AtWRNexo-p for the 
indicated periods of time (A) or with indicated amounts of AtWRNexo-p for 1h at 22°C (B). 
rent DNA substrates 
AtWRNexo-p was assayed on different DNA substrates to determine its substrate 
requirements (Fig. 20). AtWRNexo-p hydrolyzes the recessed strand of DNA duplexes (see 
The length of single-stranded DNA present on each side of the duplex region is 13nt. Products 
of DNA hydrolysis were resolved by electrophoresis on a 20% polyacrylamide – 7 M urea 
gel. The length of degraded fragment is indicated. It was determined using labeled DNA 
oligonucleotides of known lengths. 
 




Fig. 18 and 19), as does hWRN-p (Kamath-Loeb et al., 1998). The efficiency of degradation 









A duplexes. DNA 
AtWRNexo-p or 
AtWRNexoE135A-p for the indicated periods of time at 22°C. Products of DNA hydrolysis 












Fig. 20. AtWRNexo-p hydrolyzes recessed and protruding strands in DN
substrates (200 fmol), were incubated with 100 fmol of either 
were resolved by electrophoresis on a 20% polyacrylamide – 7M urea gel. Degradation of 




Notably, AtWRNexo-p is able to degrade also the protruding strand of the same DNA 
substrate (Fig. 20A). The result of this degradation is a pattern of labeled oligonucleotides 
varying in length  from  15 to 26  nucleotides dependent of the extent of degradation of the 
recessed DNA strand. This is an important difference to hWRN-p, which was reported to be 
unable to degrade protruding strands of DNA duplexes (Kamath-Loeb et al., 1998). 
Similarly to hWRN-p, single-stranded DNA and double-stranded DNA with blunt ends are 
hardly degraded by AtWRNexo-p (Fig. 20, B and C). The mutant protein AtWRNexoE135A-
p is not able to process any of the substrates tested, indicating that the observed activities 
belong to the recombinant AtWRNexo-p and that this purified protein is free of contaminating 
endo- or exonuclease activities. 
 
P for the reaction catalyzed by 
AtWRNexo-p 
The concentration and nature of divalent cations is influencing the specificity and efficiency 
of various exonuclease reactions. Therefore the activity of AtWRNexo-p was assayed in the 
presence of different divalent cations (Fig. 21, see also section 4. 6.). We found that the 
presence of Mg2+ is required for optimal exonucleolytic activity of AtWRNexo-p. The activity 
remains stable even over the broad range of ion concentration (90 – 95% of DNA substrate 
egraded in the presence of 2 – 16mM Mg2+). Mg2+ can be partially substituted by Mn2+ at 
wer concentrations (62 – 66% of DNA substrate degraded in the presence of 2 – 6mM 
n2+). Higher Mn2+ concentrations have an inhibitory effect on the exonuclease activity. Zn2+ 
romotes only weak DNA degradation (only 23% of DNA was hydrolyzed at 4mM Zn2+). In 





presence of Ca2+ no significant AtWRNexo-p activity was observed. Cations alone were not 
responsible for DNA degradation and AtWRNexoE135A-p was unable to process the DNA 






ig. 21. AtWRNexo-p needs MgCl2 or MnCl2 for exonucleolytic digestion. The duplex DNA 
(oligonucleotides *1 + 3, 200 fmol; see section 3. 4. and and 4. 4.) was incubated with 100 
ZnCl2 for 15min at 22°C. Products of DNA hydrolysis were resolved by electrophoresis on a 
ide – 7M urea gel and the ratio between full-length oligonucleotide and 
degradation products was determined by PhosphorImager analysis. 
7 % of substrate remained undigested in all cases (Figure 22). 
 
F
fmol of AtWRNexo-p in the presence of indicated concentrations of MgCl2, MnCl2, CaCl2 or 
20% polyacrylam
 
It was reported for hWRN-p that ATP stimulates the WRN exonuclease activity on duplexes 
with 3’-recessed ends (Kamath-Loeb et al., 1998). ATP is required for structure dependent 
binding of hWRN-p to DNA, while its hydrolysis allows the exonucleolytic degradation 
(Shen and Loeb, 2000). However, another report demonstrated that ATP hydrolysis is not 
required for and has no significant effect on the hWRN-p exonuclease activity on DNA 
oligonucleotides that form a bubble-like secondary structure (Machwe et al., 2002). When 
AtWRNexo-p was incubated with duplex DNA with a 3’-recessed end and the influence of 
ATP and its analogue with increased metabolic stability, ATPγS, on exonuclease activity was 
tested, no difference in DNA substrate degradation has been observed. Quantification of the 
ratio between full-length oligonucleotides and degradation products revealed no significant 













partial duplex DNA (200 
ol) was incubated with indicated amounts of AtWRNexo-p either without ATP or in the 
presence of 1mM ATP or ATPγS, respectively. Reactions were carried out at 22°C for 5 







Fig. 22. AtWRNexo-p is not stimulated by ATP or ATPγS. The 
fm
minutes. Products of DNA hydrolysis were resolved by electrophoresis through a 20% 
determined using labeled DNA oligonucleotides of known lengths. 
 
5.3.7. The processing of DNA modifications and bulky lesions by 
AtWRNexo-p 
One can speculate that in vivo the exonuclease activity of AtWRNexo-p might be required 
during the repair of damaged DNA to remove damaged nucleotides. As described for hWRN-
p previously, certain damaged or modified nucleotides incorporated into the DNA substrate, 
inhibit or block the exonucleolytic activity (Machwe et al., 2000). To investigate a possible 
function of AtWRNexo-p in DNA damage processing and to compare its activities with those 




degradation was tested. Double-stranded DNA substrates with a 5’-protruding tail, that 
ontained in the labeled strands modifications, were used. These modifications included 
elix-distorting lesions (apurinic site and cholesterol adduct), minor base modifications (8-
xoguanine, 8-oxoadenine and ethenoadenine) and unusual bases (uracil and hypoxanthine) 
igure 23). The sequences of oligonucleotides and the positions of respective modifications 
re shown in section 3.5..  
tWRNexo-p is not inhibited by uracil and hypoxanthine (Fig. 24A and Fig. 25A). Only weak 
hibition at the position 3’ to the modification could be observed using the substrate with 
thenoadenine (Fig. 25B). On the contrary, the exonuclease is strongly inhibited by an 
purinic site and completely blocked by a cholesterol adduct (Fig. 25, A and B). AtWRNexo-p 
 also inhibited by 8-oxoguanine (8-oxoG) and 8-oxoadenine (8-oxoA) at lower enzyme 
oncentrations. Higher enzyme concentrations allow the exonuclease to pass the damaged 
ucleotide, in the case of 8-oxoA to a higher degree (Fig. 24B). Importantly, AtWRNexo-p is 
.3.8. Activity of AtWRNexo-p on modified recessed 3’-DNA ends 













able to start the degradation of all DNA substrates. The unmodified substrate was fully 
degraded after the same time of incubation using 100 fmol of AtWRNexo-p. 
 
5
For hWRN-p it was reported that its exonuclease, which is homologous to the 3’ → 5’ 
proofreading dom
recessed strand with a single 3’-mismatched nucleotide (Kamath-Loeb et al., 1998), 
suggesting a possible proofreading activity of hWRN-p during DNA replication. Therefore 
was AtWRNexo-p tested on DNA substrates containing matched and one or two mismatched 
nucleotides on the 3’-recessed end (Fig. 26 A, B and C). DNA substrate (200 fmol) was 
incubated with 100 fmol of either AtWRNexo-p or AtWRNexoE135A-p for indicated periods 


















Fig. 24. Exonucleolytic activity of AtWRNexo-p is markedly inhibited on substrates 
containing 8-oxoguanine (8-oxoG), 8-oxoadenine (8-oxoA). The DNA substrates (200 fmol) 
were incubated with indicated amounts of AtWRNexo-p for 1h at 22°C. Products of DNA 
hydrolysis were resolved by electrophoresis on a 20% polyacrylamide – 7M urea gel. The 
DNA sequences contain a modified base [uracil (A), 8-oxoG, 8-oxoA (B)], its respective 
position is indicated in blue. The positions of the fragments representing the modifications is 
shown on the right site of the figure. The length of degraded fragments is indicated. It was 
determined using labeled DNA oligonucleotides of known lengths. 
 
the first 10sec about a third higher than that of the complementary terminal nucleotide. 
Further time intervals revealed the similar extent of degradation for both matched and a single 
’-mismatched nucleotide. The hydrolysis of DNA containing two 3’-mismatched nucleotides 
as less efficient. After 15min of the reaction only about 60% of the DNA substrate was 
ydrolyzed (Fig. 27). In comparison to hWRN-p, which hardly degrades a 3’-end with two 











f the figure. The length of 
DNA oligonucleotides of 
nown lengths. 
FIG. 25. Exonucleolytic activity of AtWRNexo-p is markedly inhibited or blocked on 
substrates containing apurinic site or cholesterol adduct. The DNA substrates (200 fmol) were 
incubated with indicated amounts of AtWRNexo-p for 1h at 22°C. Products of DNA 
hydrolysis were resolved by electrophoresis on a 20% polyacrylamide – 7M urea gel. The 
DNA sequences contain a modified base [hypoxanthine, apurinic site (A), ethenoadenine and 
cholesterol adduct (B)], its respective position is indicated in blue. The positions of the 
fragments representing the modifications is shown on the right site o
egraded fragments is indicated. It was determined using labeled d
k
 
To determine the ability of AtWRNexo-p to start the digestion also from 3’-PO4 termini, the 
DNA substrate containing a 3’-PO4 recessed strand was incubated with 100 fmol of either 
AtWRNexo-p or AtWRNexoE135A-p for the indicated periods of time at 22°C (Fig. 28). The 
hydrolysis of the substrate by AtWRNexo-p is similarly efficient for both types of termini 















two mismatched nucleotides at the recessed 3’-terminus. The DNA substrates (200 fmol) 
indicated periods of time at 22°C. Products of DNA hydrolysis were resolved by 
 3’-terminus 
of the recessed DNA strand are indicated as black points. The length of degraded fragments is 













Fig. 26. Exonucleolytic activity of AtWRNexo-p on DNA substrates with matched, one or 
were incubated with 100 fmol of either AtWRNexo-p or AtWRNexoE135A-p for the 




Fig. 27. Exonucleolytic activity of AtWRNexo-p on DNA substrates with matched, one or 
o mismatched nucleotides at the recessed 3’-terminus. The ratio between full-length 
ligonucleotide and degradation products was determined by PhosphorImager analysis (see 















Fig. 28. Exonucleolytic activity of AtWRNexo-p on DNA terminating with 3’-PO4 group. 
The DNA substrate (200 fmol) was incubated with 100 fmol of either AtWRNexo-p or 
AtWRNexoE135A-p for the indicated periods of time at 22°C. Products of DNA hydrolysis 
were resolved by electrophoresis on a 20% polyacrylamide – 7M urea gel. The length of 





Fig. 29. Comparison of the extent of degradation of DNA with 3’-PO4 group and the DNA 
terminating with 3’-OH (see also Figure 18A).  
 
5.3.9. Activity of AtWRNexo-p on substrates containing RNA 
 has been reported that WRN helicase unwinds RNA/DNA heteroduplexes (Suzuki et al., 
997) and the N-terminal fragments of human and mouse Werner syndrome protein degrade 
e 3’-recessed DNA strands in DNA/RNA heteroduplexes (Huang et al., 2000). AtWRNexo-
 was therefore tested, whether it can also proceed such substrates. The assay revealed that 
tWRNexo-p digests the 3’-recessed DNA strand of DNA/RNA heteroduplex in a time 
ependent manner. On the contrary, the mutant AtWRNexoE135A-p had no activity on this 
ubstrate (Figure 30). 
urthermore, because of the similarity of the N-terminal region of Werner syndrome protein 










single-stranded RNA. As shown in the Figure 30, the activity of AtWRNexo-p on single 
stranded RNA is poor, suggesting that for its degradation a complementary strand might be 




exonucleolytic activity belongs only to AtWRNexo-p and this purified protein is free of any 











ic activity of AtWRNexo-p on DNA/RNA heteroduplex and single-
stranded RNA. The DNA/RNA or RNA substrate (200 fmol) was incubated with 100 fmol of 
Products of DNA hydrolysis were resolved by electrophoresis on a 20% polyacrylamide – 7M 












either AtWRNexo-p or AtWRNexoE135A-p for the indicated periods of time at 22°C. 







5.4. Identification of interacting partners of AtWRNexo protein 
Many eukaryotic transcription factors are composed of physically separable, functionally 
independent domains – DNA-binding domain (BD) and activation domain (AD). Both are 
required to activate a transcription of target ge s and normally are part of the same protein. 
When separated from each other, they do not directly interact and thus cannot activate the 
target genes. However, if they are brought in ity in the promoter 
region, the transcription is activated. The genes encoding proteins that potentially interact 
with each other are cloned into two different v ctors to generate hybrid proteins fused either 
to the DNA binding-domain or to the activation domain. An interaction of tested proteins 
brings both BD and AD together and the transcription of target genes can occur. This is a 
principal of the two-hybrid assays, which were used to identify the interacting partners of 
AtWRNexo protein. We used two different two-hybrid systems in order to detect more 
protein-protein interactions.  It is possible that some types of protein-protein interaction are 
ot detected in a GAL4-based system, but may be detectable in a LexA system and vice versa.  
s the AtWRNexo gene doesn’t posses any RecQ-like sequence motifs, the question arises, 
hether AtWRNexo protein may interact with any of the smaller AtRecQl proteins to form 
e functional analogue of the human Werner syndrome protein. Therefore at that time, 
tRecQl1, AtRecQl2 and AtRecQl3 proteins fused to the DNA binding domain and 
tWRNexo protein fused to the activation domain were tested for the possible interaction in 
AL4 two-hybrid system. A strong interaction between AtWRNexo protein and AtRecQl2 
 
ne









protein already after 4 h X-gal staining was detected. On the contrary, no interaction between 
AtWRNexo protein and AtRecQl1 or AtRecQl2 proteins was observed, even when the 


















Fig. 31. The protein-protein interaction analysis using the GAL4 two-hybrid system. 






AtWRNexo protein showed a strong interaction with AtRecQl2 protein after 4 h X-gal 
AtWRNexo proteins or AtRecQl3 and AtWRNexo proteins were X-gal stained for 12 h 
in the upper part of the figure.   
stem and the results of the analysis are 
ummarized in Figure 32. 
without resulting in a positive signal. As a positive control the SNF1 + 4 interaction is shown 
 
During the time further factors involved in DNA recombination and DNA repair from 
Arabidopsis thaliana were identified in our group. Based on the broad spectrum of human 
Werner syndrome protein interactions (see section 1.5.), these factors were tested for the 
possible interactions with AtWRNexo protein using LexA two-hybrid system. Opposite to the 
GAL4 two-hybrid system, where the hybrid proteins are expressed constitutively, this system 
allows an inducible expression of fusion proteins and thus to analyze potentially toxic 










AtRecQl4a Self activation of AtRecQl4a 
AtRecQl5 Blue colour after 42 h 
AtRecQsim - 





AtMLH1 Blue colour after 18 h 
pB42AD/pGILDA AtWRNexo 
AtKu80 Blue colour after 24 h 
AtUbc9 Blue colour after 42 h 
Positive control p53 
SV40 large T-antigen Blue colour after 18 h 
 
Fig. 32. The protein-protein interactions tested in LexA two-hybrid assay. In the red colour 
re written the respective vectors, in which the genes encoding the tested protein were cloned. 
he positive control (written in green) represents the interaction of indicated proteins. No 
teraction is depicted as “minus”. A different degree of a blue colour shows a different 
s found between proteins AtWRNexo and AtMLH1 or 
AtWRNexo. Already after 18 h of incubation with X-gal substrate the yeast colonies turned 
blue as in the positive control. These two interactions activated also the second reporter gene 
LEU2 and grew comparable as a positive control on the mediums lacking leucine. A weaker 
interaction showed proteins AtWRNexo and AtRecQl5. For the colour development 42 h of 
X-gal staining were needed to obtain blue colour of lower intensity than that by the positive 
control. A second reporter gene LEU2 was also weaker activated. AtRecQl4a fused to the BD 
revealed strong self-activation of both reporter genes. The growth and colour development 
was same as by the positive control. It suggests that AtRecQl4a posseses itself a transcription 
activation domain. Similarly, the self-activation phenomenon was observed also by 
AtWRNexo protein, but this self-activation was very weak (slightly blue colour after 48 h of 




strength of interactions. Weaker interactions are represented as a light blue colour, very strong 
interactions as a very dark blue colour. The time needed for blue colour development is 
indicated.  
 




Interestingly  were detected, when the proteins were connected to the 
opposite fusion than they had before and tested for the interaction. It can be due to the fact, 
that the fused DNA-binding or activation domain occlud or that the 
hybrid protein f ly. The intensity of the stain eraction of 
proteins AtWRNexo and AtUbc9 is similar to the interaction of AtWRNexo and AtRecQl5. 
The colour caused by the interaction of AtWRNexo with AtKu80 was visible after 24 h 
indicating th  stronger than that between AtWRNexo and AtRecQl5 or 
AtUbc9 proteins, but weaker than between AtWRNexo an 1 proteins. 
That the prote also supported by an activation of the second reporter gene 




e the site of interaction 
olds improper ing indicates that the int
at this interaction is
d AtWRNexo or AtMLH


















6.1. Comparison of the exonucleolytic activities of AtWRNexo-p and 
hWRN-p 
The seven RecQ homologues were identified in Arabidopsis thaliana. One RecQ homologue 
differs from the others by another arrangement of the helicase domain (Figure 12). 
Additionally to the usual RecQ domains, other domains in some AtRecQ proteins have been 
identified (Bagherieh-Najjar et al., 2003). Instead of the complete homologue of WRN protein 
a small ORF (AtWRNexo) with striking similarity to only the exonuclease domain of the 
human Werner syndrome protein is present in the Arabidopsis genome (Hartung et al., 2000). 
To investigate whether it encodes the functional exonuclease and to determine its substrate 
requirements, this ORF was cloned into the expression vector and the protein was produced.  
The product of the ORF possesses indeed exonuclease activity (see Figure 18). Using a one–
step affinity chromatography purified CBP-tagged AtWRNexo protein (AtWRNexo-p) we 
have identified similarities but also significant differences in the processing of DNA 
substrates of AtWRNexo-p in comparison to the human Werner exonuclease. Both possess a 
’ → 5’ exonuclease activity cleaving 3’-recessed ends of partial dsDNA molecules. 
tWRNexo-p additionally digests also protruding strands of duplexes. Single-stranded DNA 
nd double-stranded DNA with blunt ends are poor substrates for both enzymes (Plchova et 
l., in press and Kamath-Loeb, 1998; Huang et al, 2000; Li and Comai, 2000). Because 
AtWRNexo-p cleaves ssDNA only poorly, digestion of 3’-protruding strands apparently 
needs a double-stranded region either to bind the enzyme or to stimulate the exonucleolytic 
activity. Degradation of such substrates by only the N-terminal part of human Werner 
ndrome protein (Huang et al, 2000; Li and Comai, 2001) revealed similar substrate 










Both, hWRN-p and AtWRNexo-p do not need ATP for their exonuclease activity. However 
protein to DNA molar ratios of 0.05 or 0.1, data not shown) or ΑΤPγS on the AtWRNexo-p 
activity on partial duplex DNA containing 3’-recessed end was observed. This is most 
probably due to the absence of the helicase/ATPase domain in AtWRNexo-p. The binding of 
ATP to the helicase part of hWRN-p might also promote a conformational change in the 
exonuclease domain which could enhance the exonuclease activity.  
The divalent ion Mg2+ is required for the exonuclease reaction. Mn2+ is able to replace Mg2+, 
Zn2+ only partially and Ca2+ not under the conditions used. The substitution of Mg2+ by Mn2+ 
in reactions catalyzed by AtWRNexo-p is in agreement with findings for hWRN-p, where 
Mn2+ was able not only to replace Mg2+ but even to allow a more extensive degradation of 
stem-loop DNA (Shen and Loeb, 2000). 
As for hWRN-p, cholesterol adduct completely blocks AtWRNexo-p and uracil, 
hypoxanthine and ethenoadenine allow AtWRNexo-p to digest through the regions containing 
these modifications (Machwe et al., 2000). On the contrary to hWRN-p, an apurinic site 
strongly inhibits but not completely blocks the exonucleolytic activity of AtWRNexo-p. 
Oxidative DNA lesions such as 8-deoxyadenine (8-oxoA) and 8-deoxyguanine (8-oxoG) 
inhibit AtWRNexo-p, but at high concentrations of the exonuclease such damaged nucleotides 
are removed. This is not the case for hWRN-p (Machwe et al., 2000). 
hWRN-p degrades a DNA substrate with a single mismatched nucleotide at the 3’-recessed 
terminus more efficiently than a DNA with a 3’-complementary terminal base but DNA 
containing two mismatched nucleotides on the 3’-recessed strand is poorly degraded 
(Kamath-Loeb et al., 1998) whereas AtWRNexo-p hydrolyzes DNA substrates without or 
with a single mismatch with almost similar efficiency.  In contrast to hWRN-p, AtWRNexo-p 
is able to digest a DNA substrate with two mismatched nucleotides at the 3’-recessed end, 
although at lower efficiency than substrates without or only with one mismatch. This 




difference might be connected to the absence of the helicase domain in AtWRNexo-p, 
because another report observed the comparable efficiency of DNA degradation without and 
with a single mismatch and decreased efficiency of cleavage as the number of mismatches 
increases when tested only the N-terminal part of hWRN-p (Huang et al., 2000).  
DNA double strand breaks can result in the formation of 3’-recessed ends, terminating with 
either a 3’-OH or a 3’-PO4 group. As hWRN-p (Kamath-Loeb et al., 1998), AtWRNexo-p is 
able to hydrolyze both kinds of substrates efficiently. 
Both AtWRNexo-p and hWRN-p (Huang et al., 2000) degrade the DNA/RNA hybrids. The 
hydrolysis of single-stranded RNA catalyzed by AtWRNexo-p is similarly weak as the 
degradation of single-stranded DNA.  
The summary of AtWRNexo-p and hWRN-p exonucleolytic activities is shown in Figure 33. 
 
6.2. What could be the reason(s) for the different activities of AtWRNexo-p 
and hWRN-p? 
In general, the experiments show that certain DNA structures are better substrates for 
AtWRNexo-p than what has been reported on hWRN-p before, indicating a somehow reduced 
substrate specificity of the plant enzyme in comparison to the human protein. This could be 
either due to experimental limitations of this approach or might indeed reflect a meaningful 
biological difference. Although the formed explanation cannot be totally excluded, the latter 
explanation is more favourable. 
One has to stress that a 27 aa N-terminal fusion of the AtWRNexo ORF to the calmodulin-
binding peptide (CBP) required for protein purification was used in these experiments. The 
attempts to eliminate this fusion by peptidase digest were always coupled with the 
precipitation of the enzyme and therefore to perform experiments with a protein without the 




fused to a N-terminal hexahistidine tag and additional amino acids from the vector (a total of 
over 40 aa) was used for the biochemical characterization (Kamath-Loeb et al., 1998; 
Machwe et al., 2000). In contrast to the studies with hWRN-p the characterization of the 
exonuclease activity of AtWRNexo-p was performed at 22°C. This is the optimal temperature 
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column the conditions, at which the substrates were tested, or peculiarities of the substrates 
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Fig. 33. Comparison of AtWRNexo-p and hWRN-p exonuclease activities. In the second 
are described. “(a)” indicates, that although the WRN exonuclease doesn’t need ATP or 
is depicted as different number of “+” (the highest activity is marked by “+++”). The 




at low protein concentration, on the right side with higher protein concentration. The fields 
 
for growth of Arabidopsis thaliana.  
This small protein may interact with other factors of the repair and recombination machinery 
concerning one mismatch show the activity relative to the fully matched nucleotide.  
 plants and in course of these interactions also the specificity of the exonuclease activity of 
AtWRNexo e modulated. Indeed two-hybri aled se ins 
involved in DNA repair and recombination that interact with AtWRNexo-p. The interaction 
of AtWRNexo protein with AtRecQl2 and AtRecQl5 may indicate that activities th side in 
a single protein chain in mammals might in plants be compleme ed in trans. Via EST search, 
homologues of AtWRNexo in Medicago sativa, Oryza sativa otus japonicus and Glycine 
max were found. Thus, this gene is common at least for higher plants. One is therefore 
tempted to speculate that during eukaryotic genome evolution both genes were fused together 
to generate a single ORF. As such a gene is present in s, Mus and 
Homo sapiens, the fusion remained stable during the animal evolution (Figure 34).  
The interaction of AtWRNexo protei ccordance with a findi
terminal fragment of human WRN exonuclease forms bo exa  
2000; Xue et al., 2002). The hWRN-p ith Ku7 nd Comai, 2000, 2001; 
Karmakar et al., 2002b; see also sec he observ on that AtWRNexo protein 
interacts with AtKu80 indicates that AtWRNexo may function together with AtKu80 in the 
same pathway as hWRN-p does. Additional observation that AtWRNexo interacts with Ubc9 
is again in agreement with that what was already reported for hWRN-p (see section 1.5.4.2).  
An interaction between hWRN-p and MLH , a protein requir in mismatch repair, has not 
been reported. However, AtWRNexo strongly interacts with AtMLH1, suggesting a possible 
in
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Fig. 34. Putative fusion event of WRN exonuclease and RecQ helicase during the animal 
animals and fungi splitted from each other. 
evolution. The fusion (in red) most probably happened 650 million years ago (mya), when 
 
 
6.3. Possible roles of hWRN-p in nucleic acid metabolism 
Beside its biochemical characterization a question of utmost importance is the possible role of 
the exonuclease in vivo. Several in vitro studies indicated possible in vivo functions of 
hWRN-p. 
 
6.3.1. Role in DNA replication 
5’ flap endonuclease/5’→3’ exonuclease (FEN-1) and 
stimulates the cleavage activity of the latter (Brosh et al., 2001c, Brosh et al., 2002b). This 
interaction implicates hWRN-p in the processing of Okazaki fragments during lagging strand 
hWRN-p is able to unwind intermediates in DNA replication and repair processes (Brosh et 





synthesis. The role of hWRN-p in DNA replication is further supported by the finding of 
interaction between hWRN-p and other proteins of the DNA replication machinery, such as 
polymerase δ (polδ), proliferating cell nuclear antigen (PCNA) or replication protein A (RPA) 
(Kamath-Loeb et al., 2001; Kamath-Loeb et al., 2000; Szekely et al., 2000; Lebel et al., 1999; 
Brosh et al., 1999). The interaction of WRN helicase with RPA allows the helicase to unwind 
long DNA duplexes up to nearly 1000 bp. Xenopus laevis FFA-1 protein which is 66% 
homologous to hWRN-p, is involved together with RPA in replication foci formation (Chen et 
al., 2001). The hWRN-p exonuclease is also active on the DNA substrates having on the 3’-
recessed strand mismatched nucleotides (Kamath-Loeb et al., 1998; Huang et al., 2000). It can 
be envisaged that misincorporated nucleotides can be removed in manner of a 3’ → 5’ 
proofreading exonuclease (Shevelev and Hübscher, 2002). DNA secondary structures, such as 
hairpins or G-quadruplexes, might impede a progression of a replication fork. WRN helicase
. A schematic model of such structures is shown 
in Figure 35. 
 
Fig. 35. Examples of DNA replication blocks. G4-DNA structure in the leading-strand 
 
 
activity enables polδ to overcome these secondary structures of the d(CGG)n trinucleotide  
epeat sequence (Kamath-Loeb et al., 2001)r
template (left) and G4-DNA-stabilized junction (right). 
 
 
The WRN helicase unwinds G4-DNA structure (Fry and Loeb, 1999; Mohagheg et al., 2001). 
Potential role of this helicase in defending genome integrity during DNA replication is shown 
in the Figure 36. 
 
Fig. 36. Possible role for the Werner syndrome protein in DNA replication. During DNA 
replication structures may arise that impede fork progression (red circle). Such structures 
might be directly processed by hWRN-p (upper part of the figure). If a fork encounters 
already the blocking lesion, the new synthesized strands might anneal to form a four-way 
junction. The leading strand could be extended using the longer lagging strand as a template. 
Branch migration catalyzed by hWRN-p might then extend the leading strand beyond the 
lesion to restore the replication fork (lower part of the figure). 
 
6.3.2. Role in DNA repair 
hWRN-p may also function in the repair of double-strand breaks by non-homologous end 
joining (NHEJ), because it was shown to interact with Ku70/Ku80 (Cooper et al, 2000, 
Karmakar et al, 2002b). Moreover, recent studies revealed an interaction with DNA-PKcs 
hich forms together with Ku70/Ku80 a complex involved in DSB repair. Displacement of 
cs t DNA ends from the exonucleolytic 
w
DNA-PKcs from DNA was achieved by addition of hWRN-p to a Ku:DNA-PKcs:DNA 




action of hWRN-p (Li and Comai, 2002). Ku70/Ku80 has been found to stimulate the 
exonucleolytic activity of hWRN-p and recruit hWRN-p to DNA (Li and Comai, 2001, 
Karmakar et al., 2002b). Involvement of hWRN-p and Ku in the same pathway is further 
supported by the observation of genetic instability, manifested by chromosomal 
translocations, DNA breakage and premature aging in Ku80 knockout mice (Vogel et al, 
1999).  
A role for the hWRN-p helicase in mitotic recombination has been suggested. The WS 
fibroblast cell lines showed a reduction in cell proliferation following mitotic recombination. 
The spontaneous mitotic recombination events in human somatic cells were measured using 
two different chromosomally integrated mitotic recombination reporter plasmids. The 
initiation of mitotic recombination is comparable in both wild type and WS cells, but WS 
cells offen fails to resolve recombinant products (Prince et al., 2001). The defective 
recombination resolution is also connected to the Rad51-dependent homologous 
recombination pathway. Rad51 plays a central role in recombinational repair and together 
with RPA coats and stabilizes single-strand DNA for a strand exchange activity. Rad51 
egative Rad51 protein led to a higher rate of surviving WS cells following DNA damage 
promotes the formation of recombination products, such as Holliday junctions, which could 
be substrates for hWRN-p. A failure to resolve these products may lead to mitotic arrest, cell 
death or genetic instability. The suppression of mitotic recombination using a dominant-
n
(Saintigny et al., 2002). 
 
6.3.3. Role in telomere maintenance 
There is also some evidence, that the hWRN protein might participate in telomere 
maintenance. The hWRN protein was shown to unwind large telomere repeat DNA complex 
(TRDC) in the presence of replication protein A (Ohsugi et al., 2000). Another report 




helicase (Fry and Loeb, 1999). Helicase/exonuclease activities disrupt and degrade D-loops in 
vitro (Orren et al., 2002). D-loop structures occur in telomeric regions (Greider, 1999; Griffith 
et al., 1999; Murti and Prescott, 1999) and are also formed during recombination. Thus, the 
loss of hWRN protein may lead to the inability of cells to process D-loops in telomeres and 
therefore to the loss of telomeric sequences. Although WS fibroblasts demonstrate a faster 
rate of telomere shortening, the senescent WS cells reveal longer telomeres compared with 
.3.4. Role in base excision repair (BER) 
ticipate in long-patch base excision repair (LP-
those of the senescent controls (Schulz et al., 1996). Recent reports revealed that the 
replicative senescence is most probably connected to an alteration in telomere structure rather 
than to a telomere length (Karlseder et al., 2002). It was also shown that the yeast WRN 
homologue Sgs1 is involved in telomere lengthening by a telomerase – independent pathway 
(Huang et al., 2001; Johnson et al., 2001; Cohen and Sinclair, 2001). Recent studies described 
the stimulation of Werner helicase activities by the telomere-binding protein TRF2 (Opresko 
et al., 2002). The Werner syndrome protein interactions with several proteins that have been 
found to localize to telomeres suggest that hWRN-p may function in a maintenance of 
telomeres. Ku interacts with the telomere binding proteins TRF1 and TRF2 (Song et al., 2000; 
Hsu et al., 2000). Ku86 also prevents the fusion of telomeric ends (Samper et al., 2000). 
Furthermore, DNA-PKcs and Mre11-Rad50-Nbs1 complex required for double-strand break 
repair localize to telomeres too (Gilley et al., 2001; Zhu et al., 2000). The schematic structure, 
how hWRN-p may be involved in a telomere maintenance is shown in Figure 37. 
 
6
The Werner syndrome protein may also par
BER). This pathway remove damaged bases with a help of different proteins (Wilson and 
Thompson, 1997). The repair pathway initiates a DNA glycosylase that recognizes and 
removes a damage base. An abasic intermediate is subsequently cleaved by an 




phosphate (dRP). In short patch pathway, the polymerase β incorporates a single nucleotide 
and a nick is sealed by DNA ligase I. When dRP is modified, polymerase replaces 
approximately 7 nucleotides. The displaced strand is then removed by FEN-1, which is 
stimulated by PCNA. A nick is again sealed by DNA ligase I. In this pathway, hWRN-p 
stimulates the displacement activity of polymerase β in a long-patch BER (Harrigan et al., 
2003). Moreover, hWRN-p interacts with FEN-1, PCNA, polymerase δ and RPA. It is 
therefore very likely, that the Werner syndrome protein participates in LP-BER (Figure 38).  
 
Fig. 37. The structure of telomeric ends. hWRN-p may process the invading strand either by 
rection of unwinding and exonucleolytic 
degradation is marked by blue arrows. Other proteins that associate with telomeric sequences 
the figure. 
the helicase or the exonuclease activity. The di









Fig. 38. The base excision repair pathway. In the blue colour are shown the proteins, which 
teract with hWRN-p either physically and/or functionally. The steps, in which may the 







6.3.5. Role in posttranscriptional gene silencing (PTGS) 
There are three genes belonging to the RecQ family of helicases in Neurospora crassa 
required for a post-transcriptional gene silencing (Cogoni and Macino, 1999; Catalanotto et 
al., 2002). The phenomenon PTGS is a process, in which a double-stranded RNA triggers 
degradation of homologous mRNA in the cytoplasm and thus promotes silencing of the gene, 
which mRNA is transcribed. This phenomenon is known also for plants, where PTGS may 
participate in plant defense against viruses. Recently, the homologue of the Werner syndrome 
exonuclease from Arabidopsis thaliana AtWRNexo protein, newly named WEX, has been 
shown to be involved in PTGS (Glazov et al., 2003). The generated mutant wex-1 revealed an 
impaired PTGS. An ectopic expression of WEX again restored the PTGS to the level of a 
wild type. It was speculated that the exonuclease may be required for the final hydrolysis of 
fragments of target RNAs.  
 
6.4. Possible roles of AtWRNexo-p in nucleic acid metabolism  
All these findings show that in humans WRN protein plays an important role in the 
maintenance of genomic stability by its involvement in the different processes of DNA 
metabolism, such as replication, recombination, repair or telomere maintenance. The 
biological role of WRN homologues in plants remains to be determined. The similarity of 
degradation of DNA substrates with 3’-recessed end, ssDNA or dsDNA with blunt ends 
support the hypothesis that the Werner-like exonuclease activities are a common feature of 
DNA metabolism in animals and plants. The ability of AtWRNexo-p to degrade also the 
ismatched nucleotides from the 3’-recessed end of the partial duplexes suggests the role for 
AtWRNexo-p as a 3’ → 5’ proofreading exonuclease in DNA replication. AtWRNexo-p is 
ot surprising, because the AtWRNexo-p possesses an exonucleolytic domain similar to a 
domain of ribonuclease D (RNaseD). The RNaseD domain reveals similarities to the 
m





proofreading domain of DNA polymerases (Moser, 1997). Thus, AtWRNexo-p may be able 
require helicase activities. AtWRNexo protein interacts with 
tMLH1. This interaction is very strong and may suggest, that AtWRNexo-p function is 
in with AtKu80 
may be important for non-homologous end joining pathway or telomere maintenance. 
Furthermore, the activity of AtWRNexo-p might be modulated by AtKu80 as it is shown for 
the WRN exonuclease (Cooper et al., 2000). AtWRNexo-p might also be posttranslationally 
modified by AtUbc9, another protein that interacts with AtWRNexo-p. This modification 
could be probably important for the regulation of the degradation of the AtWRNexo protein.  
 
to degrade both DNA and RNA and therefore might also be involved in some aspect of 
mRNA degradation during posttranscriptional gene silencing. Indeed, pilot experiments 
showed that partially duplex RNA molecules could be digested by this enzyme (Plchova, 
unpublished). AtWRNexo-p is similarly to the WRN exonuclease inhibited or blocked by 
certain type of DNA lesions. It is therefore possible that AtWRNexo-p may potentially be 
involved in sensing such damaged nucleotides and may need the participation of other protein 
partners for their removal. Interactions of the AtWRNexo-p and several members of the 
AtRecQl helicase family in the two hybrid assay indicate that the exonuclease function is 
involved in processes that require RecQl-helicase activities. Since this exonuclease is not 
physically linked to a helicase, one is tempted to speculate that it might be involved also in 
processes, which do not 
A
required for mismatch repair in plants. The interaction of AtWRNexo prote
6.5. Outlook 
In this study, the Werner-like exonuclease from Arabidopsis thaliana (AtWRNexo-p) was 
biochemically characterized. The characterization revealed similarities but also significant 
differences to the human Werner syndrome exonuclease. AtWRNexo-p is able to 
exonucleolytically degrade DNA/RNA hybrids and weakly single-stranded RNA. A recent 




therefore interesting to investigate, whether this exonuclease can degrade also substrates 
postulated to occur during the PTGS process, and RNAs of pathogens like viroids.  
The two-hybrid assays revealed the interactions between AtWRNexo protein and other 
proteins required for different aspect of genome maintenance. The purification and 
biochemical characterization of AtRecQ-like and AtRecQsim proteins will provide an insight 
in the possible roles of these enzymes in vivo. Furthermore, the isolation of AtRecQl2 and 
AtRecQl5 proteins, found to interact with AtWRNexo protein in vivo, will allow to confirm 
these interactions on the protein level. Some secondary DNA structures, such as bubbles, are 
not possible to degrade by only an N-terminal part of the Werner syndrome protein and 
require the helicase part of WRN protein for a degradation (Machwe et al., 2002). It will be 
therefore interesting to determine, if AtWRNexo-p together with one of the other AtRecQ 
proteins will hydrolyze such structures.  
The heterodimer Ku stimulates the exonucleolytic activity of hWRN-p (Cooper et al., 2000). 
The expression and purification of AtKu heterodimer will allow to test such effect on 
AtWRNexo-p.  
Many proteins were identified to interact with hWRN-p. Thus, it will be interesting to identify 
other putative interacting partners from Arabidopsis thaliana. This will give us a new insight 
in which pathways the AtWRNexo protein may participate. 
Besides defining partners of the exonuclease by two-hybrid screens, the analysis of T-DNA 
sertion lines will help to elucidate the function of AtWRNexo-p in vivo. It will be important 
re length of such mutant plants, as it has been postulated for human, that the 
in
to test the telome
Werner syndrome protein may participate in telomere maintenance. Moreover, the 








The aim of this study was the characterization of the Werner syndrome exonuclease 
om activities of the human WRN exonuclease. The 
gest 3’-protruding strands. DNA with recessed 3’-PO4 and 3’-OH termini is 
holesterol adducts and oxidative 
o identify possible interaction partners of AtWRNexo protein, its ORF was cloned also into 
e vectors used in GAL4 and LexA two-hybrid systems. Additionally, the ORFs of putative 
teraction partner were also cloned into these vectors. An interaction between AtWRNexo 
homologue (AtWRNexo-p) from Arabidopsis thaliana.  
The human Werner syndrome protein (hWRN-p) possessing DNA helicase and exonuclease 
activities is essential for genome stability. Plants have no homologue of this bifunctional 
protein, but surprisingly a small ORF (AtWRNexo) with homology to the exonuclease 
domain of hWRN-p was identified in Arabidopsis genome. To identify a function and 
determine the substrate specificity of AtWRNexo protein (AtWRNexo-p), the ORF was 
cloned into an expression vector and expressed in E. coli as a 27 aa calmoduline-binding 
peptide fusion-protein. Purified AtWRNexo-p was incubated with different DNA substrates. 
The analysis revealed that AtWRNexo-p is indeed an exonuclease with activities that are 
similar but also significantly different fr
protein digests recessed strands of DNA duplexes in 3’ → 5’ direction but hardly single–
stranded DNA or blunt-ended duplexes. In contrast to the Werner exonuclease, AtWRNexo-p 
is also able to di
degraded to a similar extent. AtWRNexo-p hydrolyzes the 3’-recessed strand termini of 
duplexes containing mismatched bases. AtWRNexo-p needs the divalent cation Mg2+ for 
activity, which can be replaced by Mn2+. Apurinic sites, c
DNA damage (such as 8-oxoadenine and 8-oxoguanine) inhibit or block the enzyme. Other 
DNA modifications, including uracil, hypoxanthine and ethenoadenine, did not inhibit 
AtWRNexo-p. DNA/RNA hybrids are also hydrolyzed by AtWRNexo-p, but the single-
stranded RNA only weakly. A mutation of a conserved residue within the exonuclease 







protein and AtMLH1, AtKu80, AtRecQl2, AtRecQl5, AtUbc9 proteins could be detected. 
Furthermore, two-hybrid analysis revealed, that AtWRNexo protein interacts with itself, 
probably, it persists as multimer in solution. 
The results indicate, that the WRN-like exonuclease activity seems to be an important feature 
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